Heme oxygenase-1 and the vascular bed: From molecular mechanisms to therapeutic opportunities

Antioxidants and Redox Signaling

Volumn 10, Issue 10, 2008, Pages 1767-1812

  Loboda, Agnieszka ^a   Jazwa, Agnieszka ^a   Grochot Przeczek, Anna ^a   Rutkowski, Andrzej J ^a   Cisowski, Jaroslaw ^a   Agarwal, Anupam ^b   Jozkowicz, Alicja ^a   Dulak, Jozef ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLSALICYLIC ACID; ANGIOTENSIN II; BILIRUBIN; BILIVERDIN; BUTYLATED HYDROXYANISOLE; CARBON MONOXIDE; CARVEDILOL; CYCLIC GMP; CYCLOSPORIN; DEFEROXAMINE; DIPIRIDYL; HEME OXYGENASE 1; HEMIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDOMETACIN; IRON CHELATING AGENT; ISOENZYME; MEVINOLIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARVOVIRUS VECTOR; PENTOXIFYLLINE; POLYPHENOL DERIVATIVE; PROBUCOL; RAPAMYCIN; RESVERATROL; ROSUVASTATIN; SIMVASTATIN; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CELL LINE; CELL PROTECTION; CELL THERAPY; CORONARY BLOOD VESSEL; DIABETES MELLITUS; DNA POLYMORPHISM; ENZYME DEFECT; ENZYME DEFICIENCY; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; HYPOXIA; INSULIN DEPENDENT DIABETES MELLITUS; KNOCKOUT MOUSE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RESTENOSIS; REVIEW; STROKE; VASOCONSTRICTION; VASODILATATION; VIRAL GENE THERAPY; WOUND HEALING;

ANIMALS; APOPTOSIS; BILIVERDINE; CARBON MONOXIDE; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CHILD; DIABETES COMPLICATIONS; ENDOTHELIUM, VASCULAR; ENZYME INDUCTION; FEMALE; GENE THERAPY; HEME; HEME OXYGENASE-1; HUMANS; INFLAMMATION; IRON; MALE; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; RABBITS; RATS; VASOMOTOR SYSTEM;

EID: 49849099361     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2008.2043     Document Type: Review

References (482)

1. Abate A, Zhao H, Wong RJ, and Stevenson DK. The role of Bach1 in the induction of heme oxygenase by tin mesoporphyrin. Biochem Biophys Res Commun 354: 757-763, 2007.
2. Abraham NG, Asija A, Drummond G, and Peterson S. Heme oxygenase-1 gene therapy: recent advances and therapeutic applications. Curr Gene Ther 7: 89-108, 2007.
3. Abraham NG, Kushida T, McClung J, Weiss M, Quan S, Lafaro R, Darzynkiewicz Z, and Wolin M. Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ Res 93: 507-514, 2003.
4. Abraham NG, Rezzani R, Rodella L, Kruger A, Taller D, Li Volti G, Goodman AI, and Kappas A. Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes. Am J Physiol Heart Circ Physiol 287: H2468-H2477, 2004.
5. Abu-Soud HM, Wu C, Ghosh DK and Stuehr DJ. Stopped-flow analysis of CO and NO binding to inducible nitric oxide synthase. Biochemistry 37: 3777-3786, 1998.
6. Aburaya M, Tanaka K, Hoshino T, Tsutsumi S, Suzuki K, Makise M, Akagi R, and Mizushima T. Heme oxygenase-1 protects gastric mucosal cells against non-steroidal anti-inflammatory drugs. J Biol Chem 281: 33422-33432, 2006.
7. Adachi T, Ishikawa K, Hida W, Matsumoto H, Masuda T, Date F, Ogawa K, Takeda K, Furuyama K, Zhang Y, Kitamuro T, Ogawa H, Maruyama Y, and Shibahara S. Hypoxemia and blunted hypoxic ventilatory responses in mice lacking heme oxygenase-2. Biochem Biophys Res Commun 320: 514-522, 2004.
8. Agarwal A and Nick HS. Renal response to tissue injury: lessons from heme oxygenase-1 gene ablation and expression. J Am Soc Nephrol 11: 965-973, 2000.
9. Ahmad Z, Salim M, and Maines MD. Human biliverdin reductase is a leucine zipper-like DNA-binding protein and functions in transcriptional activation of heme oxygenase-1 by oxidative stress. J Biol Chem 277: 9226-9232, 2002.
10. Aizawa T, Ishizaka N, Taguchi J, Kimura S, Kurokawa K, and Ohno M. Balloon injury does not induce heme oxygenase-1 expression, but administration of hemin inhibits neointimal formation in balloon-injured rat carotid artery. Biochem Biophys Res Commun 261: 302-307, 1999.
11. Aizawa T, Ishizaka N, Kurokawa K, Nagai R, Nakajima H, Taguchi J, and Ohno M. Different effects of angiotensin II and catecholamine on renal cell apoptosis and proliferation in rats. Kidney Int 59: 645-653, 2001.
12. Aizawa T, Ishizaka N, Taguchi J, Nagai R, Mori I, Tang SS, Ingelfinger JR, and Ohno M. Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats: possible role in renoprotection. Hypertension 35: 800-806, 2000.
13. Alam J and Den Z. Distal AP-1 binding sites mediate basal level enhancement and TPA induction of the mouse heme oxygenase-1 gene. J Biol Chem 267: 21894-21900, 1992.
14. Alam J and Cook JL. Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway. Curr Pharm Des 9: 2499-2511, 2003.
15. Alam J, Shibahara S, and Smith A. Transcriptional activation of the heme oxygenase gene by heme and cadmium in mouse hepatoma cells. J Biol Chem 264: 6371-6375, 1989.
16. Alam J, Cai J, and Smith A. Isolation and characterization of the mouse heme oxygenase-1 gene: distal 5′ sequences are required for induction by heme or heavy metals. J Biol Chem 269: 1001-1009, 1994.
17. Alam J, Camhi S, and Choi AM. Identification of a second region upstream of the mouse heme oxygenase-1 gene that functions as a basal level and inducer-dependent transcription enhancer. J Biol Chem 270: 11977-11984, 1995.
18. Alam J, Wicks C, Stewart D, Gong P, Touchard C, Otterbein S, Choi AM, Burow ME, and Tou J. Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells: role of p38 kinase and Nrf2 transcription factor. J Biol Chem 275: 27694-27702, 2000.
19. Alcaraz MJ, Habib A, Creminon C, Vicente AM, Lebret M, Levy-Toledano S, and Maclouf J. Heme oxygenase-1 induction by nitric oxide in RAW 264.7 macrophages is upregulated by a cyclo-oxygenase-2 inhibitor. Biochim Biophys Acta 1526: 13-16, 2001.
20. Ali F, Hamdulay SS, Kinderlerer AR, Boyle JJ, Lidington EA, Yamaguchi T, Soares MP, Haskard DO, Randi AM, and Mason JC. Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1. J Thromb Haemost 5: 2537-2546, 2007.
21. Alvarez-Maqueda M, El Bekay R, Alba G, Monteseirin J, Chacon P, Vega A, Martin-Nieto J, Bedoya FJ, Pintado E, and Sobrino F. 15-Deoxy-delta 12,14-prostaglandin J2 induces heme oxygenase-1 gene expression in a reactive oxygen species-dependent manner in human lymphocytes. J Biol Chem 279: 21929-21937, 2004.
22. Andrews NC, Erdjument-Bromage H, Davidson MB, Tempst P, and Orkin SH. Erythroid transcription factor NFE2 is a haematopoietic-specific basic-leucine zipper protein. Nature 362: 722-728, 1993.
23. Angermayr B, Mejias M, Gracia-Sancho J, Garcia-Pagan JC, Bosch J, and Fernandez M. Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats. J Hepatol 44: 1033-1039, 2006.
24. Anwar AA, Li FY, Leake DS, Ishii T, Mann GE, and Siow RC. Induction of heme oxygenase 1 by moderately oxidized low-density lipoproteins in human vascular smooth muscle cells: role of mitogen-activated protein kinases and Nrf2. Free Radic Biol Med 39: 227-236, 2005.
25. Appleton SD, Marks GS, Nakatsu K, Brien JF, Smith GN, Graham CH, and Lash GE. Effects of hypoxia on heme oxygenase expression in human chorionic villi explants and immortalized trophoblast cells. Am J Physiol Heart Circ Physiol 284: H853-H858, 2003.
26. Baan C, Peeters A, Lemos F, Uitterlinden A, Doxiadis I, Claas F, Ijzermans J, Roodnat J, and Weimar W. Fundamental role for HO-1 in the self-protection of renal allografts. Am J Transplant 4: 811-818, 2004.
27. Bainbridge SA and Smith GN. HO in pregnancy. Free Radic Biol Med 38: 979-988, 2005.
28. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW, and Vercellotti GM. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem 267: 18148-18153, 1992.
29. Balla J, Vercellotti GM, Jeney V, Yachie A, Varga Z, Jacob HS, Eaton JW, and Balla G. Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and dies) in an iron-rich environment. Antioxid Redox Signal 9: 2119-2138, 2007.
30. Balogun E, Hoque M, Gong P, Killeen E, Green CJ, Foresti R, Alam J, and Motterlini R. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J 371: 887-895, 2003.
31. Baranano DE, Rao M, Ferris CD, and Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci U S A 99: 16093-16098, 2002.
32. Baranano DE, Wolosker H, Bae BI, Barrow RK, Snyder SH, and Ferris CD. A mammalian iron ATPase induced by iron. J Biol Chem 275: 15166-15173, 2000.
33. Bauer I, Rensing H, Florax A, Ulrich C, Pistorius G, Redl H, and Bauer M. Expression pattern and regulation of heme oxygenase-1/heat shock protein 32 in human liver cells. Shock 20: 116-122, 2003.
34. Baum M, Schiff E, Kreiser D, Dennery PA, Stevenson DK, Rosenthal T, and Seidman DS. End-tidal carbon monoxide measurements in women with pregnancy-induced hypertension and preeclampsia. Am J Obstet Gynecol 183: 900-903, 2000.
35. Behrendt D and Ganz P. Endothelial function: from vascular biology to clinical applications. Am J Cardiol 90: 40L-48L, 2002.
36. Beierwaltes WH. Induction of heme oxygenase: can it really reverse hypertension? Hypertension 48: 555-557, 2006.
37. Benvenisti-Zarom L and Regan RF. Astrocyte-specific heme oxygenase-1 hyperexpression attenuates heme-mediated oxidative injury. Neurobiol Dis 26: 688-695, 2007.
38. Berberat PO, Katori M, Kaczmarek E, Anselmo D, Lassman C, Ke B, Shen X, Busuttil RW, Yamashita K, Csizmadia E, Tyagi S, Otterbein LE, Brouard S, Tobiasch E, Bach FH, Kupiec-Weglinski JW, and Soares MP. Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J 17: 1724-1726, 2003.
39. Berezikov E and Plasterk RH. Camels and zebrafish, viruses and cancer: a microRNA update. Hum Mol Genet 14 Spec No. 2: R183-R190, 2005.
40. Bhaskaran M, Reddy K, Radhakrishanan N, Franki N, Ding G, and Singhal PC. Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Renal Physiol 284: F955-F965, 2003.
41. Boehning D, Sedaghat L, Sedlak TW, and Snyder SH. Heme oxygenase-2 is activated by calcium-calmodulin. J Biol Chem 279: 30927-30930, 2004.
42. Boehning D, Moon C, Sharma S, Hurt KJ, Hester LD, Ronnett GV, Shugar D, and Snyder SH. Carbon monoxide neurotransmission activated by CK2 phosphorylation of heme oxygenase-2. Neuron 40: 129-137, 2003.
43. Borthwick GM, Johnson AS, Partington M, Burn J, Wilson R, and Arthur HM. Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism. FASEB J 20: 2009-2016, 2006.
44. Botros FT, Schwartzman ML, Stier CT Jr, Goodman AI, and Abraham NG. Increase in heme oxygenase-1 levels ameliorates renovascular hypertension. Kidney Int 68: 2745-2755, 2005.
45. Bouche D, Chauveau C, Roussel JC, Mathieu P, Braudeau C, Tesson L, Soulillou JP, Iyer S, Buelow R, and Anegon I. Inhibition of graft arteriosclerosis development in rat aortas following heme oxygenase-1 gene transfer. Transplant Immunol 9: 235-238, 2002.
46. Boutros CN, Zegdi R, Lila N, Combillau M, Fornes P, Carpentier A, and Noel Fabiani J. Pulmonary expression of inducible heme-oxygenase after ischemia/reperfusion of the lower extremities in rats. J Surg Res 129: 306-312, 2005.
47. Brouard S, Berberat PO, Tobiasch E, Seldon MP, Bach FH, and Soares MP. Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-kappa B to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis. J Biol Chem 277: 17950-17961, 2002.
48. Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AM, and Soares MP. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192: 1015-1026, 2000.
49. Brown J, Reading SJ, Jones S, Fitchett CJ, Howl J, Martin A, Longland CL, Michelangeli F, Dubrova YE, and Brown CA. Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/83. Lab Invest 80: 37-45, 2000.
50. Bruce CR, Carey AL, Hawley JA, and Febbraio MA. Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. Diabetes 52: 2338-2345, 2003.
51. Brune B and Ullrich V. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol 32: 497-504, 1987.
52. Brydun A, Watari Y, Yamamoto Y, Okuhara K, Teragawa H, Kono F, Chayama K, Oshima T, and Ozono R. Reduced expression of heme oxygenase-1 in patients with coronary atherosclerosis. Hypertens Res 30: 341-348, 2007.
53. Buckley BJ, Marshall ZM, and Whorton AR. Nitric oxide stimulates Nrf2 nuclear translocation in vascular endothelium. Biochem Biophys Res Commun 307: 973-979, 2003.
54. Busserolles J, Megias J, Terencio MC, and Alcaraz MJ. Heme oxygenase-1 inhibits apoptosis in Caco-2 cells via activation of Akt pathway. Int J Biochem Cell Biol 38: 1510-1517, 2006.
55. Bussolati B and Mason JC. Dual role of VEGF-induced heme-oxygenase-1 in angiogenesis. Antioxid Redox Signal 8: 1153-1163, 2006.
56. Bussolati B, Ahmed A, Pemberton H, Landis RC, Di Carlo F, Haskard DO, and Mason JC. Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood 103: 761-766, 2004.
57. Cajone F and Bernelli-Zazzera A. Oxidative stress induces a subset of heat shock proteins in rat hepatocytes and MH1C1 cells. Chem Biol Interact 65: 235-246, 1988.
58. Cardell LO, Ueki IF, Stjarne P, Agusti C, Takeyama K, Linden A, and Nadel JA. Bronchodilatation in vivo by carbon monoxide, a cyclic GMP related messenger. Br J Pharmacol 124: 1065-1068, 1998.
59. Caterina JJ, Donze D, Sun CW, Ciavatta DJ, and Townes TM. Cloning and functional characterization of LCR-F1: a bZIP transcription factor that activates erythroid-specific, human globin gene expression. Nucleic Acids Res 22: 2383-2391, 1994.
60. Chae HJ, Chin HY, Lee GY, Park HR, Yang SK, Chung HT, Pae HO, Kim HM, Chae SW, and Kim HR. Carbon monoxide and nitric oxide protect against tumor necrosis factor-alpha-induced apoptosis in osteoblasts: HO-1 is necessary to mediate the protection. Clin Chim Acta 365: 270-278, 2006.
61. Chang KW, Lee TC, Yeh WI, Chung MY, Liu CJ, Chi LY, and Lin SC. Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers. Br J Cancer 91: 1551-1555, 2004.
62. Chen-Roetling J and Regan RF. Effect of heme oxygenase-1 on the vulnerability of astrocytes and neurons to hemoglobin. Biochem Biophys Res Commun 350: 233-237, 2006.
63. Chen-Roetling J, Benvenisti-Zarom L and Regan RF. Cultured astrocytes from heme oxygenase-1 knockout mice are more vulnerable to heme-mediated oxidative injury. J Neurosci Res 82: 802-810, 2005.
64. Chen CY, Jang JH, Li MH, and Surh YJ. Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res Commun 331: 993-1000, 2005.
65. Chen JC, Huang KC, and Lin WW. HMG-CoA reductase inhibitors upregulate heme oxygenase-1 expression in murine RAW264.7 macrophages via ERK, p38 MAPK and protein kinase G pathways. Cell Signal 18: 32-39, 2006.
66. Chen K and Maines MD. Nitric oxide induces heme oxygenase-1 via mitogen-activated protein kinases ERK and p38. Cell Mol Biol (Noisy-le-grand) 46: 609-617, 2000.
67. Chen K, Gunter K, and Maines MD. Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J Neurochem 75: 304-313, 2000.
68. Chen S, Sega M, and Agarwal A. "Lumen digestion" technique for isolation of aortic endothelial cells from heme oxygenase-1 knockout mice. Biotechniques 37: 84-86, 88-89, 2004.
69. Chen S, Khan ZA, Barbin Y, and Chakrabarti S. Pro-oxidant role of heme oxygenase in mediating glucose-induced endothelial cell damage. Free Radic Res 38: 1301-1310, 2004.
70. Chen S, Kapturczak MH, Wasserfall C, Glushakova OY, Campbell-Thompson M, Deshane JS, Joseph R, Cruz PE, Hauswirth WW, Madsen KM, Croker BP, Berns KI, Atkinson MA, Flotte TR, Tisher CC, and Agarwal A. Interleukin 10 attenuates neointimal proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway. Proc Natl Acad Sci U S A 102: 7251-7256, 2005.
71. Chen XB, Li YX, Jiao Y, Dong WP, Li G, Chen J, and Tan JM. Influence of heme oxygenase-1 gene transfer on the viability and function of rat islets in in vitro culture. World J Gastroenterol 13: 1053-1059, 2007.
72. Chen XL, Varner SE, Rao AS, Grey JY, Thomas S, Cook CK, Wasserman MA, Medford RM, Jaiswal AK, and Kunsch C. Laminar flow induction of antioxidant response element-mediated genes in endothelial cells: a novel anti-inflammatory mechanism. J Biol Chem 278: 703-711, 2003.
73. Chen YH, Tsai HL, Chiang MT, and Chau LY. Carbon monoxide-induced early thrombolysis contributes to heme oxygenase-1-mediated inhibition of neointimal growth after vascular injury in hypercholesterolemic mice. J Biomed Sci 13: 721-730, 2006.
74. Chen YH, Chau LY, Lin MW, Chen LC, Yo MH, Chen JW, and Lin SJ. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with angiographic restenosis after coronary stenting. Eur Heart J 25: 39-47, 2004.
75. Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW, Charng MJ, Wu TC, Chen LC, Ding YA, Pan WH, Jou YS, and Chau LY. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 111: 1-8, 2002.
76. Chin BY, Jiang G, Wegiel B, Wang HJ, Macdonald T, Zhang XC, Gallo D, Cszimadia E, Bach FH, Lee PJ, and Otterbein LE. Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci U S A 104: 5109-5114, 2007.
77. Chlopicki S, Olszanecki R, Marcinkiewicz E, Lomnicka M, and Motterlini R. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase. Cardiovasc Res 71: 393-401, 2006.
78. Christou H, Morita T, Hsieh CM, Koike H, Arkonac B, Perrella MA, and Kourembanas S. Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ Res 86: 1224-1229, 2000.
79. Chua CC, Hamdy RC, and Chua BH. Upregulation of vascular endothelial growth factor by H2O2 in rat heart endothelial cells. Free Radic Biol Med 25: 891-897, 1998.
80. Cilla DD Jr, Whitfield LR, Gibson DM, Sedman AJ, and Posvar EL. Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMGCoA reductase, in healthy subjects. Clin Pharmacol Ther 60: 687-695, 1996.
81. Cisowski J, Loboda A, Jozkowicz A, Chen S, Agarwal A, and Dulak J. Role of heme oxygenase-1 in hydrogen peroxide-induced VEGF synthesis: effect of HO-1 knockout. Biochem Biophys Res Commun 326: 670-676, 2005.
82. Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, and Motterlini R. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol 278: H643-H651, 2000.
83. Clark JE, Naughton P, Shurey S, Green CJ, Johnson TR, Mann BE, Foresti R, and Motterlini R. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 93: e2-e8, 2003.
84. Cosso L, Maineri EP, Traverso N, Rosatto N, Pronzato MA, Cottalasso D, Marinari UM, and Odetti P. Induction of heme oxygenase 1 in liver of spontaneously diabetic rats. Free Radic Res 34: 189-191, 2001.
85. Courtney AE, McNamee PT, Middleton D, Heggarty S, Patterson CC, and Maxwell AP. Association of functional heme oxygenase-1 gene promoter polymorphism with renal transplantation outcomes. Am J Transplant 7: 908-913, 2007.
86. Crichton RR, Wilmet S, Legssyer R, and Ward RJ. Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J Inorg Biochem 91: 9-18, 2002.
87. Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, Devey LR, Wigmore SJ, Abbas A, Hewett PW, and Ahmed A. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 115: 1789-1797, 2007.
88. Cukiernik M, Mukherjee S, Downey D, and Chakabarti S. Heme oxygenase in the retina in diabetes. Curr Eye Res 27: 301-308, 2003.
89. da Silva JL, Stoltz RA, Dunn MW, Abraham NG, and Shibahara S. Diminished heme oxygenase-1 mRNA expression in RPE cells from diabetic donors as quantitated by competitive RT/PCR. Curr Eye Res 16: 380-386, 1997.
90. Das S, Fraga CG, and Das DK. Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFkappaB. Free Radic Res 40: 1066-1075, 2006.
91. Datla SR, Dusting GJ, Mori TA, Taylor CJ, Croft KD, and Jiang F. Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress. Hypertension 50: 636-642, 2007.
92. Datta D, Dormond O, Basu A, Briscoe DM, and Pal S. Heme oxygenase-1 modulates the expression of the anti-angiogenic chemokine CXCL-10 in renal tubular epithelial cells. Am J Physiol Renal Physiol 293: F1222-F1230, 2007.
93. Datta PK, Koukouritaki SB, Hopp KA, and Lianos EA. Heme oxygenase-1 induction attenuates inducible nitric oxide synthase expression and proteinuria in glomerulonephritis. J Am Soc Nephrol 10: 2540-2550, 1999.
94. Datta PK, Moulder JE, Fish BL, Cohen EP, and Lianos EA. Induction of heme oxygenase 1 in radiation nephropathy: role of angiotensin II. Radiat Res 155: 734-739, 2001.
95. Dawson TM and Snyder SH. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J Neurosci 14: 5147-5159, 1994.
96. Demougeot C, Van Hoecke M, Bertrand N, Prigent-Tessier A, Mossiat C, Beley A, and Marie C. Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2,2′-dipyridyl in the rat photothrombotic ischemic stroke model. J Pharmacol Exp Ther 311: 1080-1087, 2004.
97. Deng YM, Wu BJ, Witting PK, and Stocker R. Probucol protects against smooth muscle cell proliferation by upregulating heme oxygenase-1. Circulation 110: 1855-1860, 2004.
98. Deramaudt BM, Braunstein S, Remy P, and Abraham NG. Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J Cell Biochem 68: 121-127, 1998.
99. Deshane J, Chen S, Caballero S, Grochot-Przeczek A, Was H, Li Calzi S, Lach R, Hock TD, Chen B, Hill-Kapturczak N, Siegal GP, Dulak J, Jozkowicz A, Grant MB, and Agarwal A. Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. J Exp Med 204: 605-618, 2007.
100. Devesa I, Ferrandiz ML, Guillen I, Cerda JM, and Alcaraz MJ. Potential role of heme oxygenase-1 in the progression of rat adjuvant arthritis. Lab Invest 85: 34-44, 2005.
101. Dhakshinamoorthy S and Porter AG. Nitric oxide-induced transcriptional up-regulation of protective genes by Nrf2 via the antioxidant response element counteracts apoptosis of neuroblastoma cells. J Biol Chem 279: 20096-20107, 2004.
102. Ding Y, McCoubrey WK Jr, and Maines MD. Interaction of heme oxygenase-2 with nitric oxide donors: is the oxygenase an intracellular "sink" for NO? Eur J Biochem 264: 854-861, 1999.
103. Donnelly LE and Barnes PJ. Expression of heme oxygenase in human airway epithelial cells. Am J Respir Cell Mol Biol 24: 295-303, 2001.
104. Dore S and Snyder SH. Neuroprotective action of bilirubin against oxidative stress in primary hippocampal cultures. Ann N Y Acad Sci 890: 167-172, 1999.
105. Dore S, Takahashi M, Ferris CD, Zakhary R, Hester LD, Guastella D, and Snyder SH. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci U S A 96: 2445-2450, 1999.
106. Dore S, Sampei K, Goto S, Alkayed NJ, Guastella D, Blackshaw S, Gallagher M, Traystman RJ, Hurn PD, Koehler RC, and Snyder SH. Heme oxygenase-2 is neuroprotective in cerebral ischemia. Mol Med 5: 656-663, 1999.
107. Dragoni S, Gori T, Lisi M, Di Stolfo G, Pautz A, Kleinert H, and Parker JD. Pentaerythrityl tetranitrate and nitroglycerin, but not isosorbide mononitrate, prevent endothelial dysfunction induced by ischemia and reperfusion. Arterioscler Thromb Vasc Biol 27: 1955-1959, 2007.
108. Drexler H and Hornig B. Endothelial dysfunction in human disease. J Mol Cell Cardiol 31: 51-60, 1999.
109. Dulak J and Jozkowicz A. Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy. Curr Cancer Drug Targets 5: 579-594, 2005.
110. Dulak J, Tomala K, Loboda A, and Jozkowicz A. Nitric oxide-dependent synthesis of vascular endothelial growth factor is impaired by high glucose. Life Sci 75: 2573-2586, 2004.
111. Dulak J, Loboda A, Zagorska A, and Jozkowicz A. Complex role of heme oxygenase-1 in angiogenesis. Antioxid Redox Signal 6: 858-866, 2004.
112. Dulak J, Jozkowicz A, Foresti R, Green C, and Motterlini R. Regulation of nitric oxide synthesis by heme oxygenase-1 in rat vascular smooth muscle cells. In: Moncada S, Gustafsson L, Wiklund P, and Higgs EA, eds. The biology of nitric oxide, part 7 (Vol. 135): London, Portland Press, 2000: p 135.
113. Dulak J, Wegrzyn J, Cisowski J, Loboda A, Agarwal A, and Jozkowicz A. Heme oxygenase-1 and angiogenesis: therapeutic implications. In: Otterbein LE, Zuckerbraun BS, eds. Heme oxygenase: the elegant orchestration of its products in medicine. New York: Nova Science, 2005:245-271.
114. Dulak J, Jozkowicz A, Foresti R, Kasza A, Frick M, Huk I, Green CJ, Pachinger O, Weidinger F, and Motterlini R. Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal 4: 229-240, 2002.
115. Dulak J, Loboda A, Jazwa A, Zagorska A, Dorler J, Alber H, Dichtl W, Weidinger F, Frick M, and Jozkowicz A. Atorvastatin affects several angiogenic mediators in human endothelial cells. Endothelium 12: 233-241, 2005.
116. Durante W and Schafer AI. Carbon monoxide and vascular cell function [Review]. Int J Mol Med 2: 255-262, 1998.
117. Durante W, Peyton KJ, and Schafer AI. Platelet-derived growth factor stimulates heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19: 2666-2672, 1999.
118. Durante W, Kroll MH, Christodoulides N, Peyton KJ, and Schafer AI. Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res 80: 557-564, 1997.
119. Endler G, Exner M, Schillinger M, Marculescu R, Sunder-Plassmann R, Raith M, Jordanova N, Wojta J, Mannhalter C, Wagner OF, and Huber K. A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery disease. Thromb Haemost 91: 155-161, 2004.
120. Exner M, Minar E, Wagner O, and Schillinger M. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 37: 1097-1104, 2004.
121. Exner M, Schillinger M, Minar E, Mlekusch W, Schlerka G, Haumer M, Mannhalter C, and Wagner O. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J Endovasc Ther 8: 433-440, 2001.
122. Exner M, Bohmig GA, Schillinger M, Regele H, Watschinger B, Horl WH, Raith M, Mannhalter C, and Wagner OF. Donor heme oxygenase-1 genotype is associated with renal allograft function. Transplantation 77: 538-542, 2004.
123. Eyssen-Hernandez R, Ladoux A, and Frelin C. Differential regulation of cardiac heme oxygenase-1 and vascular endothelial growth factor mRNA expressions by hemin, heavy metals, heat shock and anoxia. FEBS Lett 382: 229-233, 1996.
124. Farhangkhoee H, Khan ZA, Mukherjee S, Cukiernik M, Barbin YP, Karmazyn M, and Chakrabarti S. Heme oxygenase in diabetes-induced oxidative stress in the heart. J Mol Cell Cardiol 35: 1439-1448, 2003.
125. Fernandez M and Bonkovsky HL. Vascular endothelial growth factor increases heme oxygenase-1 protein expression in the chick embryo chorioallantoic membrane. Br J Pharmacol 139: 634-640, 2003.
126. Ferrara N, Gerber HP, and LeCouter J. The biology of VEGF and its receptors. Nat Med 9: 669-676, 2003.
127. Ferris CD, Jaffrey SR, Sawa A, Takahashi M, Brady SD, Barrow RK, Tysoe SA, Wolosker H, Baranano DE, Dore S, Poss KD, and Snyder SH. Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol 1: 152-157, 1999.
128. Fondevila C, Katori M, Lassman C, Carmody I, Busuttil RW, Bach FH, and Kupiec-Weglinski JW. Biliverdin protects rat livers from ischemia/reperfusion injury. Transplant Proc 35: 1798-1799, 2003.
129. Foo RS, Siow RC, Brown MJ, and Bennett MR. Heme oxygenase-1 gene transfer inhibits angiotensin II-mediated rat cardiac myocyte apoptosis but not hypertrophy. J Cell Physiol 209: 1-7, 2006.
130. Foresti R, Clark JE, Green CJ, and Motterlini R. Thiol compounds interact with nitric oxide in regulating heme oxygenase-1 induction in endothelial cells: involvement of superoxide and peroxynitrite anions. J Biol Chem 272: 18411-18417, 1997.
131. Foresti R, Hammad J, Clark JE, Johnson TR, Mann BE, Friebe A, Green CJ, and Motterlini R. Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule. Br J Pharmacol 142: 453-460, 2004.
132. Frampton JE and Brogden RN. Pentoxifylline (oxpentifylline): a review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders. Drugs Aging 7: 480-503, 1995.
133. Fujita T, Toda K, Karimova A, Yan SF, Naka Y, Yet SF, and Pinsky DJ. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med 7: 598-604, 2001.
134. Furchgott RF and Jothianandan D. Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 28: 52-61, 1991.
135. Gao M, Kondo F, Murakami T, Xu JW, Ma N, Zhu X, Mori K, and Ishida T. 1-Aminocyclopropanecarboxylic acid, an antagonist of N-methyl-D-aspartate receptors, causes hypotensive and antioxidant effects with upregulation of heme oxygenase-1 in stroke-prone spontaneously hypertensive rats. Hypertens Res 30: 249-257, 2007.
136. Ghattas MH, Chuang LT, Kappas A, and Abraham NG. Protective effect of HO-1 against oxidative stress in human hepatoma cell line (HepG2) is independent of telomerase enzyme activity. Int J Biochem Cell Biol 34: 1619-1628, 2002.
137. Gong P, Stewart D, Hu B, Li N, Cook J, Nel A, and Alam J. Activation of the mouse heme oxygenase-1 gene by 15-deoxy-Delta(12,14)-prostaglandin J(2) is mediated by the stress response elements and transcription factor Nrf2. Antioxid Redox Signal 4: 249-257, 2002.
138. Goodman AI, Quan S, Yang L, Synghal A, and Abraham NG. Functional expression of human heme oxygenase-1 gene in renal structure of spontaneously hypertensive rats. Exp Biol Med (Maywood) 228: 454-458, 2003.
139. Goto J, Ishikawa K, Kawamura K, Watanabe Y, Matumoto H, Sugawara D, and Maruyama Y. Heme oxygenase-1 reduces murine monocrotaline-induced pulmonary inflammatory responses and resultant right ventricular overload. Antioxid Redox Signal 4: 563-568, 2002.
140. Graser T, Vedernikov YP, and Li DS. Study on the mechanism of carbon monoxide induced endothelium-independent relaxation in porcine coronary artery and vein. Biomed Biochim Acta 49: 293-296, 1990.
141. Grosser N, Erdmann K, Hemmerle A, Berndt G, Hinkelmann U, Smith G, and Schroder H. Rosuvastatin upregulates the antioxidant defense protein heme oxygenase-1. Biochem Biophys Res Commun 325: 871-876, 2004.
142. Grosser N, Abate A, Oberle S, Vreman HJ, Dennery PA, Becker JC, Pohle T, Seidman DS, and Schroder H. Heme oxygenase-1 induction may explain the antioxidant profile of aspirin. Biochem Biophys Res Commun 308: 956-960, 2003.
143. Grosser N, Hemmerle A, Berndt G, Erdmann K, Hinkelmann U, Schurger S, Wijayanti N, Immenschuh S, and Schroder H. The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells. Free Radic Biol Med 37: 2064-2071, 2004.
144. Grundemar L and Ny L. Pitfalls using metalloporphyrins in carbon monoxide research. Trends Pharmacol Sci 18: 193-195, 1997.
145. Grzenkowicz-Wydra J, Cisowski J, Nakonieczna J, Zarebski A, Udilova N, Nohl H, Jozkowicz A, Podhajska A, and Dulak J. Gene transfer of CuZn superoxide dismutase enhances the synthesis of vascular endothelial growth factor. Mol Cell Biochem 264: 169-181, 2004.
146. Gulesserian T, Wenzel C, Endler G, Sunder-Plassmann R, Marsik C, Mannhalter C, Iordanova N, Gyongyosi M, Wojta J, Mustafa S, Wagner O, and Huber K. Clinical restenosis after coronary stent implantation is associated with the heme oxygenase-1 gene promoter polymorphism and the heme oxygenase-1 +99G/C variant. Clin Chem 51: 1661-1665, 2005.
147. Gullu H, Erdogan D, Tok D, Topcu S, Caliskan M, Ulus T, and Muderrisoglu H. High serum bilirubin concentrations preserve coronary flow reserve and coronary microvascular functions. Arterioscler Thromb Vasc Biol 25: 2289-2294, 2005.
148. Gunther L, Berberat PO, Haga M, Brouard S, Smith RN, Soares MP, Bach FH, and Tobiasch E. Carbon monoxide protects pancreatic beta-cells from apoptosis and improves islet function/survival after transplantation. Diabetes 51: 994-999, 2002.
149. Guo Y, Stein AB, Wu WJ, Tan W, Zhu X, Li QH, Dawn B, Motterlini R, and Bolli R. Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 286: H1649-H1653, 2004.
150. Han F, Takeda K, Yokoyama S, Ueda H, Shinozawa Y, Furuyama K, and Shibahara S. Dynamic changes in expression of heme oxygenases in mouse heart and liver during hypoxia. Biochem Biophys Res Commun 338: 653-659, 2005.
151. Hancock WW, Buelow R, Sayegh MH, and Turka LA. Antibody-induced
152. Hangaishi M, Ishizaka N, Aizawa T, Kurihara Y, Taguchi J, Nagai R, Kimura S, and Ohno M. Induction of heme oxygenase-1 can act protectively against cardiac ischemia/reperfusion in vivo. Biochem Biophys Res Commun 279: 582-588, 2000.
153. Hartsfield CL. Cross talk between carbon monoxide and nitric oxide. Antioxid Redox Signal 4: 301-307, 2002.
154. Haugen EN, Croatt AJ, and Nath KA. Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro. Kidney Int 58: 144-152, 2000.
155. Hayashi K, Haneda M, Koya D, Maeda S, Isshiki K, and Kikkawa R. Enhancement of glomerular heme oxygenase-1 expression in diabetic rats. Diabetes Res Clin Pract 52: 85-96, 2001.
156. Hayashi S, Omata Y, Sakamoto H, Higashimoto Y, Hara T, Sagara Y, and Noguchi M. Characterization of rat heme oxygenase-3 gene: implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene 336: 241-250, 2004.
157. Hayashi S, Takamiya R, Yamaguchi T, Matsumoto K, Tojo SJ, Tamatani T, Kitajima M, Makino N, Ishimura Y, and Suematsu M. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ Res 85: 663-671, 1999.
158. He JQ, Ruan J, Connett JE, Anthonisen NR, Pare PD, and Sandford AJ. Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers. Am J Respir Crit Care Med 166: 323-328, 2002.
159. Hentze MW, Muckenthaler MU, and Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell 117: 285-297, 2004.
160. Hesheng O, Jun Y, Ligia T, Yongzheng P, Chaoshu T, Jingyi S, and Naikui L. Role of endogenous carbon monoxide in neointimal formation induced by balloon-injury in rat aorta. Chin Med Sci J 14: 41-45, 1999.
161. Hill-Kapturczak N, Thamilselvan V, Liu F, Nick HS, and Agarwal A. Mechanism of heme oxygenase-1 gene induction by curcumin in human renal proximal tubule cells. Am J Physiol Renal Physiol 281: F851-F859, 2001.
162. Hill-Kapturczak N, Voakes C, Garcia J, Visner G, Nick HS, and Agarwal A. A cis-acting region regulates oxidized lipid-mediated induction of the human heme oxygenase-1 gene in endothelial cells. Arterioscler Thromb Vasc Biol 23: 1416-1422, 2003.
163. Hill-Kapturczak N, Sikorski E, Voakes C, Garcia J, Nick HS, and Agarwal A. An internal enhancer regulates heme- and cadmium-mediated induction of human heme oxygenase-1. Am J Physiol Renal Physiol 285: F515-F523, 2003.
164. Hirai H, Kubo H, Yamaya M, Nakayama K, Numasaki M, Kobayashi S, Suzuki S, Shibahara S, and Sasaki H. Microsatellite polymorphism in heme oxygenase-1 gene promoter is associated with susceptibility to oxidant-induced apoptosis in lymphoblastoid cell lines. Blood 102: 1619-1621, 2003.
165. Hirai K, Sasahira T, Ohmori H, Fujii K, and Kuniyasu H. Inhibition of heme oxygenase-1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL mice. Int J Cancer 120: 500-505, 2007.
166. Hock TD, Nick HS, and Agarwal A. Upstream stimulatory factors, USF1 and USF2, bind to the human haem oxygenase-1 proximal promoter in vivo and regulate its transcription. Biochem J 383: 209-218, 2004.
167. Hock TD, Liby K, Wright M, McConnell S, Schorpp-Kistner M, Ryan TM, and Agarwal A. JunB and JunD regulate human heme oxygenase-1 gene expression in renal epithelial cells. J Biol Chem 282: 6875-6886, 2007.
168. Hosoya T, Maruyama A, Kang MI, Kawatani Y, Shibata T, Uchida K, Warabi E, Noguchi N, Itoh K, and Yamamoto M. Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells. J Biol Chem 280: 27244-27250, 2005.
169. Hsieh CH, Rau CS, Hsieh MW, Chen YC, Jeng SF, Lu TH, and Chen SS. Simvastatin-induced heme oxygenase-1 increases apoptosis of Neuro 2A cells in response to glucose deprivation. Toxicol Sci 101: 112-121, 2007.
170. Hsu M, Muchova L, Morioka I, Wong RJ, Schroder H, and Stevenson DK. Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo. Biochem Biophys Res Commun 343: 738-744, 2006.
171. Hu CM, Chen YH, Chiang MT, and Chau LY. Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo. Circulation 110: 309-316, 2004.
172. Hu CM, Lin HH, Chiang MT, Chang PF, and Chau LY. Systemic expression of heme oxygenase-1 ameliorates type 1 diabetes in NOD mice. Diabetes 56: 1240-1247, 2007.
173. Huang FP, Xi G, Keep RF, Hua Y, Nemoianu A, and Hoff JT. Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J Neurosurg 96: 287-293, 2002.
174. Hussain AS, Marks GS, Brien JF, and Nakatsu K. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-alpha] quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate. Can J Physiol Pharmacol 75: 1034-1037, 1997.
175. Immenschuh S, Iwahara S, Satoh H, Nell C, Katz N, and Muller-Eberhard U. Expression of the mRNA of heme-binding protein 23 is coordinated with that of heme oxygenase-1 by heme and heavy metals in primary rat hepatocytes and hepatoma cells. Biochemistry 34: 13407-13411, 1995.
176. Inamdar NM, Ahn YI, and Alam J. The heme-responsive element of the mouse heme oxygenase-1 gene is an extended AP-1 binding site that resembles the recognition sequences for MAF and NF-E2 transcription factors. Biochem Biophys Res Commun 221: 570-576, 1996.
177. Ishii T, Itoh K, Ruiz E, Leake DS, Unoki H, Yamamoto M, and Mann GE. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ Res 94: 609-616, 2004.
178. Ishikawa K, Navab M, Leitinger N, Fogelman AM, and Lusis AJ. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest 100: 1209-1216, 1997.
179. Ishikawa K, Sugawara D, Wang X, Suzuki K, Itabe H, Maruyama Y, and Lusis AJ. Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice. Circ Res 88: 506-512, 2001.
180. Ishikawa K, Sugawara D, Goto J, Watanabe Y, Kawamura K, Shiomi M, Itabe H, and Maruyama Y. Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Circulation 104: 1831-1836, 2001.
181. Ishizaka N and Griendling KK. Heme oxygenase-1 is regulated by angiotensin II in rat vascular smooth muscle cells. Hypertension 29: 790-795, 1997.
182. Ishizaka N, de Leon H, Laursen JB, Fukui T, Wilcox JN, De Keulenaer G, Griendling KK and Alexander RW. Angiotensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta. Circulation 96: 1923-1929, 1997.
183. Itoh K, Mochizuki M, Ishii Y, Ishii T, Shibata T, Kawamoto Y, Kelly V, Sekizawa K, Uchida K, and Yamamoto M. Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2). Mol Cell Biol 24: 36-45, 2004.
184. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, and Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236: 313-322, 1997.
185. Jazwa A, Loboda A, Golda S, Cisowski J, Szelag M, Zagorska A, Sroczynska P, Drukala J, Jozkowicz A, and Dulak J. Effect of heme and heme oxygenase-1 on vascular endothelial growth factor synthesis and angiogenic potency of human keratinocytes. Free Radic Biol Med 40: 1250-1263, 2006.
186. Jeney V, Balla J, Yachie A, Varga Z, Vercellotti GM, Eaton JW, and Balla G. Pro-oxidant and cytotoxic effects of circulating heme. Blood 100: 879-887, 2002.
187. Jofre-Monseny L, Loboda A, Wagner AE, Huebbe P, Boesch-Saadatmandi C, Jozkowicz A, Minihane AM, Dulak J, and Rimbach G. Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression. Biochem Biophys Res Commun 357: 319-324, 2007.
188. Johnson FK and Johnson RA. Carbon monoxide promotes endothelium-dependent constriction of isolated gracilis muscle arterioles. Am J Physiol Regul Integr Comp Physiol 285: R536-R541, 2003.
189. Johnson FK, Teran FJ, Prieto-Carrasquero M, and Johnson RA. Vascular effects of a heme oxygenase inhibitor are enhanced in the absence of nitric oxide. Am J Hypertens 15: 1074-1080, 2002.
190. Johnson RA, Kozma F, and Colombari E. Carbon monoxide: from toxin to endogenous modulator of cardiovascular functions. Braz J Med Biol Res 32: 1-14, 1999.
191. Johnson RA, Lavesa M, DeSeyn K, Scholer MJ, and Nasjletti A. Heme oxygenase substrates acutely lower blood pressure in hypertensive rats. Am J Physiol 271: H1132-1138, 1996.
192. Johnson RA, Teran FJ, Durante W, Peyton KJ, and Johnson FK. Enhanced heme oxygenase-mediated coronary vasodilation in Dahl salt-sensitive hypertension. Am J Hypertens 17: 25-30, 2004.
193. Jones CI 3rd, Zhu H, Martin SF, Han Z, Li Y, and Alevriadou BR. Regulation of antioxidants and phase 2 enzymes by shear-induced reactive oxygen species in endothelial cells. Ann Biomed Eng 35: 683-693, 2007.
194. Jozkowicz A and Dulak J. Effects of protoporphyrins on production of nitric oxide and expression of vascular endothelial growth factor in vascular smooth muscle cells and macrophages. Acta Biochim Pol 50: 69-79, 2003.
195. Jozkowicz A, Huk I, Nigisch A, Weigel G, Weidinger F, and Dulak J. Effect of prostaglandin-J(2) on VEGF synthesis depends on the induction of heme oxygenase-1. Antioxid Redox Signal 4: 577-585, 2002.
196. Jozkowicz A, Huk I, Nigisch A, Weigel G, Dietrich W, Motterlini R, and Dulak J. Heme oxygenase and angiogenic activity of endothelial cells: stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX. Antioxid Redox Signal 5: 155-162, 2003.
197. Juan SH, Cheng TH, Lin HC, Chu YL, and Lee WS. Mechanism of concentration-dependent induction of heme oxygenase-1 by resveratrol in human aortic smooth muscle cells. Biochem Pharmacol 69: 41-48, 2005.
198. Juan SH, Lee TS, Tseng KW, Liou JY, Shyue SK, Wu KK, and Chau LY. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 104: 1519-1525, 2001.
199. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, and Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 97: 3422-3427, 2000.
200. Kaneda H, Ohno M, Taguchi J, Togo M, Hashimoto H, Ogasawara K, Aizawa T, Ishizaka N, and Nagai R. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol 22: 1680-1685, 2002.
201. Kawashima A, Oda Y, Yachie A, Koizumi S, and Nakanishi I. Heme oxygenase-1 deficiency: the first autopsy case. Hum Pathol 33: 125-130, 2002.
202. Ke B, Buelow R, Shen XD, Melinek J, Amersi F, Gao F, Ritter T, Volk HD, Busuttil RW, and Kupiec-Weglinski JW. Heme oxygenase 1 gene transfer prevents CD95/Fas ligand-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway. Hum Gene Ther 13: 1189-1199, 2002.
203. Keyse SM and Tyrrell RM. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci U S A 86: 99-103, 1989.
204. Kikuchi A, Yamaya M, Suzuki S, Yasuda H, Kubo H, Nakayama K, Handa M, Sasaki T, Shibahara S, Sekizawa K, and Sasaki H. Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism. Hum Genet 116: 354-360, 2005.
205. Kim EH, Na HK and Surh YJ. Upregulation of VEGF by 15-deoxy-Delta12,14- prostaglandin J2 via heme oxygenase-1 and ERK1/2 signaling in MCF-7 cells. Ann N Y Acad Sci 1090: 375-384, 2006.
206. Kim HJ, So HS, Lee JH, Lee JH, Park C, Park SY, Kim YH, Youn MJ, Kim SJ, Chung SY, Lee KM, and Park R. Heme oxygenase-1 attenuates the cisplatin-induced apoptosis of auditory cells via down-regulation of reactive oxygen species generation. Free Radic Biol Med 40: 1810-1819, 2006.
207. Kim HP, Wang X, Zhang J, Suh GY, Benjamin IJ, Ryter SW, and Choi AM. Heat shock protein-70 mediates the cytoprotective effect of carbon monoxide: involvement of p38 beta MAPK and heat shock factor-1. J Immunol 175: 2622-2629, 2005.
208. Kim KM, Pae HO, Zhung M, Park R, Kim YM, and Chung HT. Carbon monoxide induces heme oxygenase-1 via activation of protein kinase R like endoplasmic reticulum kinase and inhibits endothelial cell apoptosis triggered by endoplasmic reticulum stress. Circ Res 101: 919-927, 2007.
209. Kimpara T, Takeda A, Watanabe K, Itoyama Y, Ikawa S, Watanabe M, Arai H, Sasaki H, Higuchi S, Okita N, Takase S, Saito H, Takahashi K, and Shibahara S. Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum Genet 100: 145-147, 1997.
210. Kinobe RT, Vlahakis JZ, Soong JM, Szarek WA, Brien JF, Longo LD, and Nakatsu K. Heme oxygenase activity in fetal and adult sheep is not altered by acclimatization to high altitude hypoxia. Can J Physiol Pharmacol 84: 893-901, 2006.
211. Kitamuro T, Takahashi K, Ogawa K, Udono-Fujimori R, Takeda K, Furuyama K, Nakayama M, Sun J, Fujita H, Hida W, Hattori T, Shirato K, Igarashi K, and Shibahara S. Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells. J Biol Chem 278: 9125-9133, 2003.
212. Kobayashi A, Ito E, Toki T, Kogame K, Takahashi S, Igarashi K, Hayashi N, and Yamamoto M. Molecular cloning and functional characterization of a new cap'n' collar family transcription factor Nrf3. J Biol Chem 274: 6443-6452, 1999.
213. Kobayashi A, Kang MI, Okawa H, Ohtsuji M, Zenke Y, Chiba T, Igarashi K, and Yamamoto M. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 24: 7130-7139, 2004.
214. Kocanova S, Buytaert E, Matroule JY, Piette J, Golab J, de Witte P, and Agostinis P. Induction of heme-oxygenase 1 requires the p38(MAPK) and PI3K pathways and suppresses apoptotic cell death following hypericin-mediated photodynamic therapy. Apoptosis 12: 731-741, 2007.
215. Kohmoto J, Nakao A, Kaizu T, Tsung A, Ikeda A, Tomiyama K, Billiar TR, Choi AM, Murase N, and McCurry KR. Low-dose carbon monoxide inhalation prevents ischemia/reperfusion injury of transplanted rat lung grafts. Surgery 140: 179-185, 2006.
216. Kong D, Melo LG, Mangi AA, Zhang L, Lopez-Ilasaca M, Perrella MA, Liew CC, Pratt RE, and Dzau VJ. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 109: 1769-1775, 2004.
217. Kortepeter M and Brown JD. A review of 79 patients with malaria seen at a military hospital in Hawaii from 1979 to 1995. Mil Med 163: 84-89, 1998.
218. Kreisberg JI. Hyperglycemia and microangiopathy: direct regulation by glucose of microvascular cells. Lab Invest 67: 416-426, 1992.
219. Kreiser D, Nguyen X, Wong R, Seidman D, Stevenson D, Quan S, Abraham N, and Dennery PA. Heme oxygenase-1 modulates fetal growth in the rat. Lab Invest 82: 687-692, 2002.
220. Kreiser D, Baum M, Seidman DS, Fanaroff A, Shah D, Hendler I, Stevenson DK, Schiff E, and Druzin ML. End tidal carbon monoxide levels are lower in women with gestational hypertension and pre-eclampsia. J Perinatol 24: 213-217, 2004.
221. Kuroki M, Voest EE, Amano S, Beerepoot LV, Takashima S, Tolentino M, Kim RY, Rohan RM, Colby KA, Yeo KT, and Adamis AP. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest 98: 1667-1675, 1996.
222. Kutty RK and Maines MD. Purification and characterization of biliverdin reductase from rat liver. J Biol Chem 256: 3956-3962, 1981.
223. Kutty RK, Nagineni CN, Kutty G, Hooks JJ, Chader GJ, and Wiggert B. Increased expression of heme oxygenase-1 in human retinal pigment epithelial cells by transforming growth factor-beta. J Cell Physiol 159: 371-378, 1994.
224. Lakkisto P, Palojoki E, Backlund T, Saraste A, Tikkanen I, Voipio-Pulkki LM, and Pulkki K. Expression of heme oxygenase-1 in response to myocardial infarction in rats. J Mol Cell Cardiol 34: 1357-1365, 2002.
225. Landar A, Shiva S, Levonen AL, Oh JY, Zaragoza C, Johnson MS, and Darley-Usmar VM. Induction of the permeability transition and cytochrome c release by 15-deoxy-Delta12,14-prostaglandin J2 in mitochondria. Biochem J 394: 185-195, 2006.
226. Lavrovsky Y, Schwartzman ML, and Abraham NG. Novel regulatory sites of the human heme oxygenase-1 promoter region. Biochem Biophys Res Commun 196: 336-341, 1993.
227. Lee PJ, Camhi SL, Chin BY, Alam J, and Choi AM. AP-1 and STAT mediate hyperoxia-induced gene transcription of heme oxygenase-1. Am J Physiol Lung Cell Mol Physiol 279: L175-L182, 2000.
228. Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, and Choi AM. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 272: 5375-5381, 1997.
229. Lee TS, Tsai HL, and Chau LY. Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12,14-prostaglandin J2. J Biol Chem 278: 19325-19330, 2003.
230. Lee TS, Shiao MS, Pan CC, and Chau LY. Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. Circulation 99: 1222-1229, 1999.
231. Lee TS, Chang CC, Zhu Y, and Shyy JY. Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 110: 1296-1302, 2004.
232. Leffler CW, Nasjletti A, Yu C, Johnson RA, Fedinec AL, and Walker N. Carbon monoxide and cerebral microvascular tone in newborn pigs. Am J Physiol 276: H1641-1646, 1999.
233. Lerner-Marmarosh N, Shen J, Torno MD, Kravets A, Hu Z, and Maines MD. Human biliverdin reductase: a member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity. Proc Natl Acad Sci U S A 102: 7109-7114, 2005.
234. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, and Karumanchi SA. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355: 992-1005, 2006.
235. Li M, Peterson S, Husney D, Inaba M, Guo K, Kappas A, Ikehara S, and Abraham NG. Long-lasting expression of HO-1 delays progression of type I diabetes in NOD mice. Cell Cycle 6: 567-571, 2007.
236. Li MH, Cha YN, and Surh YJ. Peroxynitrite induces HO-1 expression via PI3K/Akt-dependent activation of NF-E2-related factor 2 in PC12 cells. Free Radic Biol Med 41: 1079-1091, 2006.
237. Li MH, Jang JH, Na HK, Cha YN, and Surh YJ. Carbon monoxide produced by heme oxygenase-1 in response to nitrosative stress induces expression of glutamate-cysteine ligase in PC12 cells via activation of phosphatidylinositol 3-kinase and Nrf2 signaling. J Biol Chem 282: 28577-28586, 2007.
238. Li N, Venkatesan MI, Miguel A, Kaplan R, Gujuluva C, Alam J, and Nel A. Induction of heme oxygenase-1 expression in macrophages by diesel exhaust particle chemicals and quinones via the antioxidant-responsive element. J Immunol 165: 3393-3401, 2000.
239. Li P, Elrayess MA, Gomma AH, Palmen J, Hawe E, Fox KM, and Humphries SE. The microsatellite polymorphism of heme oxygenase-1 is associated with baseline plasma IL-6 level but not with restenosis after coronary in-stenting. Chin Med J (Engl) 118: 1525-1532, 2005.
240. Li P, Jiang H, Yang L, Quan S, Dinocca S, Rodriguez F, Abraham NG, and Nasjletti A. Angiotensin II induces carbon monoxide production in the perfused kidney: relationship to protein kinase C activation. Am J Physiol Renal Physiol 287: F914-F920, 2004.
241. Li Volti G, Seta F, Schwartzman ML, Nasjletti A, and Abraham NG. Heme oxygenase attenuates angiotensin II-mediated increase in cyclooxygenase-2 activity in human femoral endothelial cells. Hypertension 41: 715-719, 2003.
242. Li Volti G, Sacerdoti D, Sangras B, Vanella A, Mezentsev A, Scapagnini G, Falck JR, and Abraham NG. Carbon monoxide signaling in promoting angiogenesis in human microvessel endothelial cells. Antioxid Redox Signal 7: 704-710, 2005.
243. Li Y, Li G, Dong W, Chen J, Lu D, and Tan J. Transplantation of rat islets transduced with human heme oxygenase-1 gene using adenovirus vector. Pancreas 33: 280-286, 2006.
244. Li YX, Li G, Dong WP, Lu DR, and Tan JM. Protection of human islets from induction of apoptosis and improved islet function with HO-1 gene transduction. Chin Med J (Engl) 119: 1639-1645, 2006.
245. Liao JK and Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45: 89-118, 2005.
246. Lin CC, Chiang LL, Lin CH, Shih CH, Liao YT, Hsu MJ, and Chen BC. Transforming growth factor-beta1 stimulates heme oxygenase-1 expression via the PI3K/Akt and NF-kappaB pathways in human lung epithelial cells. Eur J Pharmacol 560: 101-109, 2007.
247. Lin Q, Weis S, Yang G, Weng YH, Helston R, Rish K, Smith A, Bordner J, Polte T, Gaunitz F, and Dennery PA. Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. J Biol Chem 282: 20621-20633, 2007.
248. Lin SC, Liu CJ, Yeh WI, Lui MT, Chang KW, and Chang CS. Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett 243: 47-54, 2006.
249. Liu X, Pachori AS, Ward CA, Davis JP, Gnecchi M, Kong D, Zhang L, Murduck J, Yet SF, Perrella MA, Pratt RE, Dzau VJ, and Melo LG. Heme oxygenase-1 (HO-1) inhibits post-myocardial infarct remodeling and restores ventricular function. FASEB J 20: 207-216, 2006.
250. Liu X, Simpson JA, Brunt KR, Ward CA, Hall SR, Kinobe RT, Barrette V, Tse MY, Pang SC, Pachori AS, Dzau VJ, Ogunyankin K, and Melo LG. Pre-emptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function one year after acute myocardial infarction. Am J Physiol Heart Circ Physiol 293: H48-H59, 2007.
251. Liu XM, Chapman GB, Peyton KJ, Schafer AI, and Durante W. Carbon monoxide inhibits apoptosis in vascular smooth muscle cells. Cardiovasc Res 55: 396-405, 2002.
252. Liu XM, Peyton KJ, Ensenat D, Wang H, Hannink M, Alam J, and Durante W. Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2/ARE complex to promote vascular smooth muscle cell survival. Cardiovasc Res 75: 381-389, 2007.
253. Liu Y, Christou H, Morita T, Laughner E, Semenza GL, and Kourembanas S. Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5′ enhancer. J Biol Chem 273: 15257-15262, 1998.
254. Lo SS, Lin SC, Wu CW, Chen JH, Yeh WI, Chung MY, and Lui WY. Heme oxygenase-1 gene promoter polymorphism is associated with risk of gastric adenocarcinoma and lymphovascular tumor invasion. Ann Surg Oncol 14: 2250-2256, 2007.
255. Lobmann R, Schultz G, and Lehnert H. Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care 28: 461-471, 2005.
256. Loboda A, Jazwa A, Wegiel B, Jozkowicz A, and Dulak J. Heme oxygenase-1-dependent and -independent regulation of angiogenic genes expression: effect of cobalt protoporphyrin and cobalt chloride on VEGF and IL-8 synthesis in human microvascular endothelial cells. Cell Mol Biol (Noisy-le-grand) 51: 347-355, 2005.
257. Loboda A, Jazwa A, Jozkowicz A, Molema G, and Dulak J. Angiogenic transcriptome of human microvascular endothelial cells: effect of hypoxia, modulation by atorvastatin. Vasc Pharmacol 44: 206-214, 2006.
258. Loboda A, Jazwa A, Jozkowicz A, Dorosz J, Balla J, Molema G, and Dulak J. Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells. Atherosclerosis 187: 26-30, 2006.
259. Loomans CJ, De Koning EJ, Staal FJ, Rabelink TJ, and Zonneveld AJ. Endothelial progenitor cell dysfunction in type 1 diabetes: another consequence of oxidative stress? Antioxid Redox Signal 7: 1468-1475, 2005.
260. Lu TH, Lambrecht RW, Pepe J, Shan Y, Kim T, and Bonkovsky HL. Molecular cloning, characterization, and expression of the chicken heme oxygenase-1 gene in transfected primary cultures of chick embryo liver cells. Gene 207: 177-186, 1998.
261. Lusis AJ. Atherosclerosis. Nature 407: 233-241, 2000.
262. Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 2: 2557-2568, 1988.
263. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37: 517-554, 1997.
264. Maines MD and Kappas A. Enzymatic oxidation of cobalt protoporphyrin IX: observations on the mechanism of heme oxygenase action. Biochemistry 16: 419-423, 1977.
265. Maines MD, Trakshel GM, and Kutty RK. Characterization of two constitutive forms of rat liver microsomal heme oxygenase: only one molecular species of the enzyme is inducible. J Biol Chem 261: 411-419, 1986.
266. Maines MD, Eke BC, and Zhao X. Corticosterone promotes increased heme oxygenase-2 protein and transcript expression in the newborn rat brain. Brain Res 722: 83-94, 1996.
267. Maines MD, Ewing JF, Huang TJ, and Panahian N. Nuclear localization of biliverdin reductase in the rat kidney: response to nephrotoxins that induce heme oxygenase-1. J Pharmacol Exp Ther 296: 1091-1097, 2001.
268. Malaguarnera L, Pilastro MR, Quan S, Ghattas MH, Yang L, Mezentsev AV, Kushida T, Abraham NG, and Kappas A. Significance of heme oxygenase in prolactin-mediated cell proliferation and angiogenesis in human endothelial cells. Int J Mol Med 10: 433-440, 2002.
269. Marquis JC and Demple B. Complex genetic response of human cells to sublethal levels of pure nitric oxide. Cancer Res 58: 3435-3440, 1998.
270. Matsumoto H, Ishikawa K, Itabe H, and Maruyama Y. Carbon monoxide and bilirubin from heme oxygenase-1 suppresses reactive oxygen species generation and plasminogen activator inhibitor-1 induction. Mol Cell Biochem 291: 21-28, 2006.
271. Maulik N. Redox signaling of angiogenesis. Antioxid Redox Signal 4: 805-815, 2002.
272. Maulik N, Sharma HS, and Das DK. Induction of the haem oxygenase gene expression during the reperfusion of ischemic rat myocardium. J Mol Cell Cardiol 28: 1261-1270, 1996.
273. Mayer M. Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem 46: 1723-1727, 2000.
274. Mazza F, Goodman A, Lombardo G, Vanella A, and Abraham NG. Heme oxygenase-1 gene expression attenuates angiotensin II-mediated DNA damage in endothelial cells. Exp Biol Med (Maywood) 228: 576-583, 2003.
275. McCarter SD, Scott JR, Lee PJ, Zhang X, Choi AM, McLean CA, Badhwar A, Dungey AA, Bihari A, Harris KA, and Potter RF. Cotransfection of heme oxygenase-1 prevents the acute inflammation elicited by a second adenovirus. Gene Ther 10: 1629-1635, 2003.
276. McCoubrey WK Jr, Ewing JF, and Maines MD. Human heme oxygenase-2: characterization and expression of a full-length cDNA and evidence suggesting that the two HO-2 transcripts may differ by choice of polyadenylation signal. Arch Biochem Biophys 295: 13-20, 1992.
277. McCoubrey WK Jr, Huang TJ, and Maines MD. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem 247: 725-732, 1997.
278. McFaul SJ and McGrath JJ. Studies on the mechanism of carbon monoxide-induced vasodilation in the isolated perfused rat heart. Toxicol Appl Pharmacol 87: 464-473, 1987.
279. McNally SJ, Harrison EM, Ross JA, Garden OJ, and Wigmore SJ. Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition. Int J Mol Med 19: 165-172, 2007.
280. Melo LG, Gnecchi M, Pachori AS, Kong D, Wang K, Liu X, Pratt RE, and Dzau VJ. Endothelium-targeted gene and cell-based therapies for cardiovascular disease. Arterioscler Thromb Vasc Biol 24: 1761-1774, 2004.
281. Melo LG, Agrawal R, Zhang L, Rezvani M, Mangi AA, Ehsan A, Griese DP, Dell'Acqua G, Mann MJ, Oyama J, Yet SF, Layne MD, Perrella MA, and Dzau VJ. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 105: 602-607, 2002.
282. Minamino T, Christou H, Hsieh CM, Liu Y, Dhawan V, Abraham NG, Perrella MA, Mitsialis SA, and Kourembanas S. Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci U S A 98: 8798-8803, 2001.
283. Minamiyama Y, Takemura S, Yamasaki K, Hai S, Hirohashi K, Funae Y, and Okada S. Continuous administration of organic nitrate decreases hepatic cytochrome P450. J Pharmacol Exp Ther 308: 729-735, 2004.
284. Mohler J, Vani K, Leung S, and Epstein A. Segmentally restricted, cephalic expression of a leucine zipper gene during Drosophila embryogenesis. Mech Dev 34: 3-9, 1991.
285. Moi P, Chan K, Asunis I, Cao A, and Kan YW. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci U S A 91: 9926-9930, 1994.
286. Moncada S and Higgs EA. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol 147(suppl 1): S193-S201, 2006.
287. Morioka I, Wong RJ, Abate A, Vreman HJ, Contag CH, and Stevenson DK. Systemic effects of orally administered zinc and tin (IV) metalloporphyrins on heme oxygenase expression in mice. Pediatr Res 59: 667-672, 2006.
288. Morita T. Heme oxygenase and atherosclerosis. Arterioscler Thromb Vasc Biol 25: 1786-1795, 2005.
289. Morita T and Kourembanas S. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest 96: 2676-2682, 1995.
290. Morita T, Perrella MA, Lee ME, and Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci U S A 92: 1475-1479, 1995.
291. Morita T, Mitsialis SA, Koike H, Liu Y, and Kourembanas S. Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J Biol Chem 272: 32804-32809, 1997.
292. Morita T, Imai T, Yamaguchi T, Sugiyama T, Katayama S, and Yoshino G. Induction of heme oxygenase-1 in monocytes suppresses angiotensin II-elicited chemotactic activity through inhibition of CCR2: role of bilirubin and carbon monoxide generated by the enzyme. Antioxid Redox Signal 5: 439-447, 2003.
293. Morsi WG, Shaker OG, Ismail EF, Ahmed HH, El-Serafi TI, Maklady FA, Abdel-Aziz MT, El-Asmar MF, and Atta HM. HO-1 and VGEF gene expression in human arteries with advanced atherosclerosis. Clin Biochem 39: 1057-1062, 2006.
294. Motohashi H, Shavit JA, Igarashi K, Yamamoto M, and Engel JD. The world according to Maf. Nucleic Acids Res 25: 2953-2959, 1997.
295. Motterlini R, Foresti R, Bassi R, and Green CJ. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 28: 1303-1312, 2000.
296. Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, and Green CJ. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 90: E17-E24, 2002.
297. Motterlini R, Sawle P, Hammad J, Bains S, Alberto R, Foresti R, and Green CJ. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB J 19: 284-286, 2005.
298. Muchova L, Wong RJ, Hsu M, Morioka I, Vitek L, Zelenka J, Schroder H, and Stevenson DK. Statin treatment increases formation of carbon monoxide and bilirubin in mice: a novel mechanism of in vivo antioxidant protection. Can J Physiol Pharmacol 85: 800-810, 2007.
299. Muller RM, Taguchi H, and Shibahara S. Nucleotide sequence and organization of the rat heme oxygenase gene. J Biol Chem 262: 6795-6802, 1987.
300. Murphy BJ, Laderoute KR, Short SM, and Sutherland RM. The identification of heme oxygenase as a major hypoxic stress protein in Chinese hamster ovary cells. Br J Cancer 64: 69-73, 1991.
301. Muto A, Hoshino H, Madisen L, Yanai N, Obinata M, Karasuyama H, Hayashi N, Nakauchi H, Yamamoto M, Groudine M, and Igarashi K. Identification of Bach2 as a B-cell-specific partner for small maf proteins that negatively regulate the immunoglobulin heavy chain gene 3′ enhancer. EMBO J 17: 5734-5743, 1998.
302. Nadal-Ginard B and Fuster V. Myocardial cell therapy at the crossroads. Nat Clin Pract Cardiovasc Med 4: 1, 2007.
303. Nakamura T, Keep RF, Hua Y, Schallert T, Hoff JT, and Xi G. Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J Neurosurg 100: 672-678, 2004.
304. Nakaso K, Kitayama M, Fukuda H, Kimura K, Yanagawa T, Ishii T, Nakashima K, and Yamada K. Oxidative stress-related proteins A170 and heme oxygenase-1 are differently induced in the rat cerebellum under kainate-mediated excitotoxicity. Neurosci Lett 282: 57-60, 2000.
305. Nakayama M, Takahashi K, Kitamuro T, Yasumoto K, Katayose D, Shirato K, Fujii-Kuriyama Y, and Shibahara S. Repression of heme oxygenase-1 by hypoxia in vascular endothelial cells. Biochem Biophys Res Commun 271: 665-671, 2000.
306. Nascimento-Silva V, Arruda MA, Barja-Fidalgo C, Villela CG, and Fierro IM. Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells. Am J Physiol Cell Physiol 289: C557-C563, 2005.
307. Nascimento AL, Luscher P, and Tyrrell RM. Ultraviolet A (320-380 nm) radiation causes an alteration in the binding of a specific protein/protein complex to a short region of the promoter of the human heme oxygenase 1 gene. Nucleic Acids Res 21: 1103-1109, 1993.
308. Ndisang JF, Zhao W. and Wang R. Selective regulation of blood pressure by heme oxygenase-1 in hypertension. Hypertension 40: 315-321, 2002.
309. Neto JS, Nakao A, Toyokawa H, Nalesnik MA, Romanosky AJ, Kimizuka K, Kaizu T, Hashimoto N, Azhipa O, Stolz DB, Choi AM, and Murase N. Low-dose carbon monoxide inhalation prevents development of chronic allograft nephropathy. Am J Physiol Renal Physiol 290: F324-F334, 2006.
310. Nowis D, Legat M, Grzela T, Niderla J, Wilczek E, Wilczynski GM, Glodkowska E, Mrowka P, Issat T, Dulak J, Jozkowicz A, Was H, Adamek M, Wrzosek A, Nazarewski S, Makowski M, Stoklosa T, Jakobisiak M, and Golab J. Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity. Oncogene 25: 3365-3374, 2006.
311. Numazawa S, Ishikawa M, Yoshida A, Tanaka S, and Yoshida T. Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress. Am J Physiol Cell Physiol 285: C334-C342, 2003.
312. Oberle S, Abate A, Grosser N, Vreman HJ, Dennery PA, Schneider HT, Stalleicken D, and Schroder H. Heme oxygenase-1 induction may explain the antioxidant profile of pentaerythrityl trinitrate. Biochem Biophys Res Commun 290: 1539-1544, 2002.
313. Ogawa K, Sun J, Taketani S, Nakajima O, Nishitani C, Sassa S, Hayashi N, Yamamoto M, Shibahara S, Fujita H, and Igarashi K. Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1. EMBO J 20: 2835-2843, 2001.
314. Oh GS, Pae HO, Moon MK, Choi BM, Yun YG, Rim JS, and Chung HT. Pentoxifylline protects L929 fibroblasts from TNF-alpha toxicity via the induction of heme oxygenase-1. Biochem Biophys Res Commun 302: 109-113, 2003.
315. Ollinger R, Yamashita K, Bilban M, Erat A, Kogler P, Thomas M, Csizmadia E, Usheva A, Margreiter R, and Bach FH. Bilirubin and biliverdin treatment of atherosclerotic diseases. Cell Cycle 6: 39-43, 2007.
316. Ollinger R, Bilban M, Erat A, Froio A, McDaid J, Tyagi S, Csizmadia E, Graca-Souza AV, Liloia A, Soares MP, Otterbein LE, Usheva A, Yamashita K, and Bach FH. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation 112: 1030-1039, 2005.
317. Ong WY and Halliwell B. Iron, atherosclerosis, and neurodegeneration: a key role for cholesterol in promoting iron-dependent oxidative damage? Ann N Y Acad Sci 1012: 51-64, 2004.
318. Orozco LD, Kapturczak MH, Barajas B, Wang X, Weinstein MM, Wong J, Deshane J, Bolisetty S, Shaposhnik Z, Shih DM, Agarwal A, Lusis AJ, and Araujo JA. Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circ Res 100: 1703-1711, 2007.
319. Otterbein LE, Mantell LL, and Choi AM. Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol 276: L688-L694, 1999.
320. Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, and Choi AM. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6: 422-428, 2000.
321. Otterbein LE, Zuckerbraun BS, Haga M, Liu F, Song R, Usheva A, Stachulak C, Bodyak N, Smith RN, Csizmadia E, Tyagi S, Akamatsu Y, Flavell RJ, Billiar TR, Tzeng E, Bach FH, Choi AM, and Soares MP. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 9: 183-190, 2003.
322. Ou HS, Yang J, Dong LW, Pang YZ, Su JY, Tang CS, and Liu NK. Role of endogenous carbon monoxide in hypertension pathogenesis of rats. Sheng Li Xue Bao 50: 643-648, 1998.
323. Oyake T, Itoh K, Motohashi H, Hayashi N, Hoshino H, Nishizawa M, Yamamoto M, and Igarashi K. Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol Cell Biol 16: 6083-6095, 1996.
324. Pachori AS, Melo LG, Zhang L, Solomon SD, and Dzau VJ. Chronic recurrent myocardial ischemic injury is significantly attenuated by pre-emptive adeno-associated virus heme oxygenase-1 gene delivery. J Am Coll Cardiol 47: 635-643, 2006.
325. Pachori AS, Smith A, McDonald P, Zhang L, Dzau VJ, and Melo LG. Heme-oxygenase-1-induced protection against hypoxia/reoxygenation is dependent on biliverdin reductase and its interaction with PI3K/Akt pathway. J Mol Cell Cardiol 43: 580-592, 2007.
326. Pae HO, Oh GS, Choi BM, Chae SC, and Chung HT. Differential expressions of heme oxygenase-1 gene in CD25-and CD25+ subsets of human CD4+ T cells. Biochem Biophys Res Commun 306: 701-705, 2003.
327. Pae HO, Oh GS, Choi BM, Kim YM, and Chung HT. A molecular cascade showing nitric oxide-heme oxygenase-1-vascular endothelial growth factor-interleukin-8 sequence in human endothelial cells. Endocrinology 146: 2229-2238, 2005.
328. Pae HO, Oh GS, Choi BM, Chae SC, Kim YM, Chung KR, and Chung HT. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol 172: 4744-4751, 2004.
329. Pagnin E, Giacon B, Zaghetto F, Vianello D, Bonfante L, Huber W, Antonello A, Semplicini A, and Calo L. [Arterial hypertension and oxidative stress induced by cyclosporin: effect of carvedilol]. Ann Ital Med Int 16: 101-105, 2001.
330. Pamplona A, Ferreira A, Balla J, Jeney V, Balla G, Epiphanio S, Chora A, Rodrigues CD, Gregoire IP, Cunha-Rodrigues M, Portugal S, Soares MP, and Mota MM. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat Med 13: 703-710, 2007.
331. Panahian N, Yoshiura M, and Maines MD. Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice. J Neurochem 72: 1187-1203, 1999.
332. Panchenko MV, Farber HW, and Korn JH. Induction of heme oxygenase-1 by hypoxia and free radicals in human dermal fibroblasts. Am J Physiol Cell Physiol 278: C92-C101, 2000.
333. Parfenova H, Basuroy S, Bhattacharya S, Tcheranova D, Qu Y, Regan RF, and Leffler CW. Glutamate induces oxidative stress and apoptosis in cerebral vascular endothelial cells: contributions of HO-1 and HO-2 to cytoprotection. Am J Physiol Cell Physiol 290: C1399-C1410, 2006.
334. Parmar KM, Nambudiri V, Dai G, Larman HB, Gimbrone MA Jr, and Garcia-Cardena G. Statins exert endothelial atheroprotective effects via the KLF2 transcription factor. J Biol Chem 280: 26714-26719, 2005.
335. Pasyk S, Wojnicz R, Szafranek A, Zielinska T, and Krupa H. [Cardiomyopathy in diabetes. Ultrastructural examinations]. Kardiol Pol 39: 439-445; discussion 446, 1993.
336. Petrache I, Otterbein LE, Alam J, Wiegand GW, and Choi AM. Heme oxygenase-1 inhibits TNF-alpha-induced apoptosis in cultured fibroblasts. Am J Physiol Lung Cell Mol Physiol 278: L312-L319, 2000.
337. Peyton KJ, Reyna SV, Chapman GB, Ensenat D, Liu XM, Wang H, Schafer AI, and Durante W. Heme oxygenase-1-derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth. Blood 99: 4443-4448, 2002.
338. Pflueger A, Croatt AJ, Peterson TE, Smith LA, d'Uscio LV, Katusic ZS, and Nath KA. The hyperbilirubinemic Gunn rat is resistant to the pressor effects of angiotensin II. Am J Physiol Renal Physiol 288: F552-F558, 2005.
339. Piantadosi CA, Zhang J, Levin ED, Folz RJ, and Schmechel DE. Apoptosis and delayed neuronal damage after carbon monoxide poisoning in the rat. Exp Neurol 147: 103-114, 1997.
340. Poss KD and Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci U S A 94: 10919-10924, 1997.
341. Poss KD and Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci U S A 94: 10925-10930, 1997.
342. Poss KD, Thomas MJ, Ebralidze AK, O'Dell TJ, and Tonegawa S. Hippocampal long-term potentiation is normal in heme oxygenase-2 mutant mice. Neuron 15: 867-873, 1995.
343. Pradhan A, Umezu M, and Fukagawa M. Heme-oxygenase upregulation ameliorates angiotensin II-induced tubulointerstitial injury and salt-sensitive hypertension. Am J Nephrol 26: 552-561, 2006.
344. Prawan A, Kundu JK, and Surh YJ. Molecular basis of heme oxygenase-1 induction: implications for chemoprevention and chemoprotection. Antioxid Redox Signal 7: 1688-1703, 2005.
345. Pugh CW, Chang GW, Cockman M, Epstein AC, Gleadle JM, Maxwell PH, Nicholls LG, O'Rourke JF, Ratcliffe PJ, Raybould EC, Tian YM, Wiesener MS, Wood M, Wykoff CC, and Yeates KM. Regulation of gene expression by oxygen levels in mammalian cells. Adv Nephrol Necker Hosp 29: 191-206, 1999.
346. Pupilli C, Lasagni L, Romagnani P, Bellini F, Mannelli M, Misciglia N, Mavilia C, Vellei U, Villari D, and Serio M. Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. J Am Soc Nephrol 10: 245-255, 1999.
347. Qu Y, Chen-Roetling J, Benvenisti-Zarom L, and Regan RF. Attenuation of oxidative injury after induction of experimental intracerebral hemorrhage in heme oxygenase-2 knockout mice. J Neurosurg 106: 428-435, 2007.
348. Quan S, Kaminski PM, Yang L, Morita T, Inaba M, Ikehara S, Goodman AI, Wolin MS, and Abraham NG. Heme oxygenase-1 prevents superoxide anion-associated endothelial cell sloughing in diabetic rats. Biochem Biophys Res Commun 315: 509-516, 2004.
349. Raju VS and Maines MD. Renal ischemia/reperfusion upregulates heme oxygenase-1 (HSP32) expression and increases cGMP in rat heart. J Pharmacol Exp Ther 277: 1814-1822, 1996.
350. Ramos KS, Lin H, and McGrath JJ. Modulation of cyclic guanosine monophosphate levels in cultured aortic smooth muscle cells by carbon monoxide. Biochem Pharmacol 38: 1368-1370, 1989.
351. Regan RF, Chen J, and Benvenisti-Zarom L. Heme oxygenase-2 gene deletion attenuates oxidative stress in neurons exposed to extracellular hemin. BMC Neurosci 5: 34, 2004.
352. Ricchetti GA, Williams LM, and Foxwell BM. Heme oxygenase 1 expression induced by IL-10 requires STAT-3 and phosphoinositol-3 kinase and is inhibited by lipopolysaccharide. J Leukoc Biol 76: 719-726, 2004.
353. Risau W. Mechanisms of angiogenesis. Nature 386: 671-674, 1997.
354. Rogers B, Yakopson V, Teng ZP, Guo Y, and Regan RF. Heme oxygenase-2 knockout neurons are less vulnerable to hemoglobin toxicity. Free Radic Biol Med 35: 872-881, 2003.
355. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 57: 791-804, 1995.
356. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 340: 115-126, 1999.
357. Rotenberg MO and Maines MD. Isolation, characterization, and expression in Escherichia coli of a cDNA encoding rat heme oxygenase-2. J Biol Chem 265: 7501-7506, 1990.
358. Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 22(suppl 4): S1-S14, 1993.
359. Ryter SW, Otterbein LE, Morse D, and Choi AM. Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem 234-235: 249-263, 2002.
360. Sabaawy HE, Zhang F, Nguyen X, ElHosseiny A, Nasjletti A, Schwartzman M, Dennery P, Kappas A, and Abraham NG. Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats. Hypertension 38: 210-215, 2001.
361. Sacerdoti D, Abraham NG, Oyekan AO, Yang L, Gatta A, and McGiff JC. Role of the heme oxygenases in abnormalities of the mesenteric circulation in cirrhotic rats. J Pharmacol Exp Ther 308: 636-643, 2004.
362. Salim M, Brown-Kipphut BA, and Maines MD. Human biliverdin reductase is autophosphorylated, and phosphorylation is required for bilirubin formation. J Biol Chem 276: 10929-10934, 2001.
363. Sanchez-Lopez E, Lopez AF, Esteban V, Yague S, Egido J, Ruiz-Ortega M, and Alvarez-Arroyo MV. Angiotensin II regulates vascular endothelial growth factor via hypoxia-inducible factor-1alpha induction and redox mechanisms in the kidney. Antioxid Redox Signal 7: 1275-1284, 2005.
364. Sardana MK and Kappas A. Dual control mechanism for heme oxygenase: tin(IV)-protoporphyrin potently inhibits enzyme activity while markedly increasing content of enzyme protein in liver. Proc Natl Acad Sci U S A 84: 2464-2468, 1987.
365. Sasaki T, Yoshida K, Kondo H, Ohmori H, and Kuniyasu H. Heme oxygenase-1 accelerates protumoral effects of nitric oxide in cancer cells. Virchows Arch 446: 525-531, 2005.
366. Sato K, Balla J, Otterbein L, Smith RN, Brouard S, Lin Y, Csizmadia E, Sevigny J, Robson SC, Vercellotti G, Choi AM, Bach FH, and Soares MP. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 166: 4185-4194, 2001.
367. Sawayama Y, Maeda S, Ohnishi H, Okada K, and Hayashi J. Effect of probucol on elderly hypercholesterolemic patients in the FAST study. Fukuoka Igaku Zasshi 97: 15-24, 2006.
368. Sawayama Y, Shimizu C, Maeda N, Tatsukawa M, Kinukawa N, Koyanagi S, Kashiwagi S, and Hayashi J. Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia: Fukuoka Atherosclerosis Trial (FAST). J Am Coll Cardiol 39: 610-616, 2002.
369. Sawle P, Foresti R, Mann BE, Johnson TR, Green CJ, and Motterlini R. Carbon monoxide-releasing molecules (CORMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br J Pharmacol 145: 800-810, 2005.
370. Scapagnini G, D'Agata V, Calabrese V, Pascale A, Colombrita C, Alkon D, and Cavallaro S. Gene expression profiles of heme oxygenase isoforms in the rat brain. Brain Res 954: 51-59, 2002.
371. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Suselbeck T, Assmus B, Tonn T, Dimmeler S, and Zeiher AM. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355: 1210-1221, 2006.
372. Schillinger M, Exner M, Mlekusch W, Domanovits H, Huber K, Mannhalter C, Wagner O, and Minar E. Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm. Thromb Res 106: 131-136, 2002.
373. Schillinger M, Exner M, Mlekusch W, Ahmadi R, Rumpold H, Mannhalter C, Wagner O, and Minar E. Heme oxygenase-1 genotype is a vascular anti-inflammatory factor following balloon angioplasty. J Endovasc Ther 9: 385-394, 2002.
374. Schillinger M, Exner M, Minar E, Mlekusch W, Mullner M, Mannhalter C, Bach FH, and Wagner O. Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor. J Am Coll Cardiol 43: 950-957, 2004.
375. Sehgal SN. Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 39: 484-489, 2006.
376. Sen CK, Khanna S, Babior BM, Hunt TK, Ellison EC, and Roy S. Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing. J Biol Chem 277: 33284-33290, 2002.
377. Sengupta S, Sellers LA, Matheson HB, and Fan TP. Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms. Br J Pharmacol 139: 219-231, 2003.
378. Shan Y, Lambrecht RW, Donohue SE, and Bonkovsky HL. Role of Bach1 and Nrf2 in up-regulation of the heme oxygenase-1 gene by cobalt protoporphyrin. FASEB J 20: 2651-2653, 2006.
379. Shan Y, Zheng J, Lambrecht RW, and Bonkovsky HL. Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes. Gastroenterology 133: 1166-1174, 2007.
380. Shapiro SM, Bhutani VK, and Johnson L. Hyperbilirubinemia and kernicterus. Clin Perinatol 33: 387-410, 2006.
381. Shi W, Wang NJ, Shih DM, Sun VZ, Wang X, and Lusis AJ. Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism. Circ Res 86: 1078-1084, 2000.
382. Shibahara S, Kitamuro T, and Takahashi K. Heme degradation and human disease: diversity is the soul of life. Antioxid Redox Signal 4: 593-602, 2002.
383. Shibahara S, Sato M, Muller RM, and Yoshida T. Structural organization of the human heme oxygenase gene and the function of its promoter. Eur J Biochem 179: 557-563, 1989.
384. Shibahara S, Han F, Li B, and Takeda K. Hypoxia and heme oxygenases: oxygen sensing and regulation of expression. Antioxid Redox Signal 9: 2209-2225, 2007.
385. Shibahara S, Yoshizawa M, Suzuki H, Takeda K, Meguro K, and Endo K. Functional analysis of cDNAs for two types of human heme oxygenase and evidence for their separate regulation. J Biochem (Tokyo) 113: 214-218, 1993.
386. Silva G, Cunha A, Gregoire IP, Seldon MP, and Soares MP. The antiapoptotic effect of heme oxygenase-1 in endothelial cells involves the degradation of p38 alpha MAPK isoform. J Immunol 177: 1894-1903, 2006.
387. Siner JM, Jiang G, Cohen ZI, Shan P, Zhang X, Lee CG, Elias JA, and Lee PJ. VEGF-induced heme oxygenase-1 confers cytoprotection from lethal hyperoxia in vivo. FASEB J 21: 1422-1432, 2007.
388. Soares MP, Usheva A, Brouard S, Berberat PO, Gunther L, Tobiasch E, and Bach FH. Modulation of endothelial cell apoptosis by heme oxygenase-1-derived carbon monoxide. Antioxid Redox Signal 4: 321-329, 2002.
389. Soares MP, Lin Y, Anrather J, Csizmadia E, Takigami K, Sato K, Grey ST, Colvin RB, Choi AM, Poss KD, and Bach FH. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 4: 1073-1077, 1998.
390. Song R, Mahidhara RS, Liu F, Ning W, Otterbein LE, and Choi AM. Carbon monoxide inhibits human airway smooth muscle cell proliferation via mitogen-activated protein kinase pathway. Am J Respir Cell Mol Biol 27: 603-610, 2002.
391. Song R, Zhou Z, Kim PK, Shapiro RA, Liu F, Ferran C, Choi AM, and Otterbein LE. Carbon monoxide promotes Fas/CD95-induced apoptosis in Jurkat cells. J Biol Chem 279: 44327-44334, 2004.
392. Song R, Mahidhara RS, Zhou Z, Hoffman RA, Seol DW, Flavell RA, Billiar TR, Otterbein LE, and Choi AM. Carbon monoxide inhibits T lymphocyte proliferation via caspase-dependent pathway. J Immunol 172: 1220-1226, 2004.
393. Song Y, Stampfer MJ, and Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 141: 137-147, 2004.
394. Spieker LE and Luscher TF. Protection of endothelial function. Handb Exp Pharmacol 619-644, 2005.
395. Stein AB, Guo Y, Tan W, Wu WJ, Zhu X, Li Q, Luo C, Dawn B, Johnson TR, Motterlini R, and Bolli R. Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. J Mol Cell Cardiol 38: 127-134, 2005.
396. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, and Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046, 1987.
397. Suh W, Kim KL, Kim JM, Shin IS, Lee YS, Lee JY, Jang HS, Lee JS, Byun J, Choi JH, Jeon ES, and Kim DK. Transplantation of endothelial progenitor cells accelerates dermal wound healing with increased recruitment of monocytes/macrophages and neovascularization. Stem Cells 23: 1571-1578, 2005.
398. Sun J, Hoshino H, Takaku K, Nakajima O, Muto A, Suzuki H, Tashiro S, Takahashi S, Shibahara S, Alam J, Taketo MM, Yamamoto M, and Igarashi K. Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J 21: 5216-5224, 2002.
399. Sunamura M, Duda DG, Ghattas MH, Lozonschi L, Motoi F, Yamauchi J, Matsuno S, Shibahara S, and Abraham NG. Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis 6: 15-24, 2003.
400. Suttner DM and Dennery PA. Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron. FASEB J 13: 1800-1809, 1999.
401. Suzuki H, Tashiro S, Hira S, Sun J, Yamazaki C, Zenke Y, Ikeda-Saito M, Yoshida M, and Igarashi K. Heme regulates gene expression by triggering Crm1-dependent nuclear export of Bach1. EMBO J 23: 2544-2553, 2004.
402. Suzuki M, Iso-o N, Takeshita S, Tsukamoto K, Mori I, Sato T, Ohno M, Nagai l, and Ishizaka N. Facilitated angiogenesis induced by heme oxygenase-1 gene transfer in a rat model of hindlimb ischemia. Biochem Biophys Res Commun 302: 138-143, 2003.
403. Sylvester JT and McGowan C. The effects of agents that bind to cytochrome P-450 on hypoxic pulmonary vasoconstriction. Circ Res 43: 429-437, 1978.
404. t Hoen PA, Van der Lans CA, Van Eck M, Bijsterbosch MK, Van Berkel TJ, and Twisk J. Aorta of ApoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes. Circ Res 93: 262-269, 2003.
405. Takahashi K, Nakayama M, Takeda K, Fujia H, and Shibahara S. Suppression of heme oxygenase-1 mRNA expression by interferon-gamma in human glioblastoma cells. J Neurochem 72: 2356-2361, 1999.
406. Takahashi S, Takahashi Y, Ito K, Nagano T, Shibahara S, and Miura T. Positive and negative regulation of the human heme oxygenase-1 gene expression in cultured cells. Biochim Biophys Acta 1447: 231-235, 1999.
407. Takeda K, Ishizawa S, Sato M, Yoshida T, and Shibahara S. Identification of a cis-acting element that is responsible for cadmium-mediated induction of the human heme oxygenase gene. J Biol Chem 269: 22858-22867, 1994.
408. Takeda M, Kikuchi M, Ubalee R, Na-Bangchang K, Ruangweerayut R, Shibahara S, Imai S, and Hirayama K. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to cerebral malaria in Myanmar. Jpn J Infect Dis 58: 268-271, 2005.
409. Taketani S, Kohno H, Yoshinaga T, and Tokunaga R. The human 32-kDa stress protein induced by exposure to arsenite and cadmium ions is heme oxygenase. FEBS Lett 245: 173-176, 1989.
410. Taketani S, Sato H, Yoshinaga T, Tokunaga R, Ishii T, and Bannai S. Induction in mouse peritoneal macrophages of 34 kDa stress protein and heme oxygenase by sulfhydryl-reactive agents. J Biochem (Tokyo) 108: 28-32, 1990.
411. Tang YL, Qian K, Zhang YC, Shen L, and Phillips MI. A vigilant, hypoxia-regulated heme oxygenase-1 gene vector in the heart limits cardiac injury after ischemia-reperfusion in vivo. J Cardiovasc Pharmacol Ther 10: 251-263, 2005.
412. Tang YL, Tang Y, Zhang YC, Qian K, Shen L, and Phillips MI. Protection from ischemic heart injury by a vigilant heme oxygenase-1 plasmid system. Hypertension 43: 746-751, 2004.
413. Tang YL, Tang Y, Zhang YC, Qian K, Shen L, and Phillips MI. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 46: 1339-1350, 2005.
414. Tenhunen R, Marver HS, and Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A 61: 748-755, 1968.
415. Tenhunen R, Marver HS, and Schmid R. Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem 244: 6388-6394, 1969.
416. Terry CM, Clikeman JA, Hoidal JR, and Callahan KS. Effect of tumor necrosis factor-alpha and interleukin-1 alpha on heme oxygenase-1 expression in human endothelial cells. Am J Physiol 274: H883-H891, 1998.
417. Thibault A, Samid D, Tompkins AC, Figg WD, Cooper MR, Hohl RJ, Trepel J, Liang B, Patronas N, Venzon DJ, Reed E, and Myers CE. Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer. Clin Cancer Res 2: 483-491, 1996.
418. Thom SR. Carbon monoxide-mediated brain lipid peroxidation in the rat. J Appl Physiol 68: 997-1003, 1990.
419. Thom SR, Fisher D, Xu YA, Notarfrancesco K, and Ischiropoulos H. Adaptive responses and apoptosis in endothelial cells exposed to carbon monoxide. Proc Natl Acad Sci U S A 97: 1305-1310, 2000.
420. Thorup C, Jones CL, Gross SS, Moore LC, and Goligorsky MS. Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS. Am J Physiol 277: F882-F889, 1999.
421. Tiroch K, Koch W, von Beckerath N, Kastrati A, and Schomig A. Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stenting. Eur Heart J 28: 968-973, 2007.
422. Togane Y, Morita T, Suematsu M, Ishimura Y, Yamazaki JI, and Katayama S. Protective roles of endogenous carbon monoxide in neointimal development elicited by arterial injury. Am J Physiol Heart Circ Physiol 278: H623-H632, 2000.
423. Tongers J, Knapp JM, Korf M, Kempf T, Limbourg A, Limbourg FP, Li Z, Fraccarollo D, Bauersachs J, Han X, Drexler H, Fiedler B, and Wollert KC. Haeme oxygenase promotes progenitor cell mobilization, neovascularization, and functional recovery after critical hind-limb ischaemia in mice. Cardiovasc Res 78: 294-300, 2008.
424. Traylor A, Hock T, and Hill-Kapturczak N. Specificity protein 1 and smad-dependent regulation of human heme oxygenase-1 gene by transforming growth factor-β1 in renal epithelial cells. Am J Physiol Renal Physiol 293: F885-F894, 2007.
425. Trigona WL, Porter CM, Horvath-Arcidiacono JA, Majumdar AS, and Bloom ET. Could heme-oxygenase-1 have a role in modulating the recipient immune response to embryonic stem cells? Antioxid Redox Signal 9: 751-756, 2007.
426. Tron K, Samoylenko A, Musikowski G, Kobe F, Immenschuh S, Schaper F, Ramadori G, and Kietzmann T. Regulation of rat heme oxygenase-1 expression by interleukin-6 via the Jak/STAT pathway in hepatocytes. J Hepatol 45: 72-80, 2006.
427. True AL, Olive M, Boehm M, San H, Westrick RJ, Raghavachari N, Xu X, Lynn EG, Sack MN, Munson PJ, Gladwin MT, and Nabel EG. Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxide. Circ Res 101: 893-901, 2007.
428. Tsai PS, Chen CC, Tsai PS, Yang LC, Huang WY, and Huang CJ. Heme oxygenase 1, nuclear factor E2-related factor 2, and nuclear factor kappaB are involved in hemin inhibition of type 2 cationic amino acid transporter expression and L-arginine transport in stimulated macrophages. Anesthesiology 105: 1201-1210; discussion 1205A, 2006.
429. Tulis DA, Keswani AN, Peyton KJ, Wang H, Schafer AI, and Durante W. Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries. Cell Mol Biol (Noisy-le-grand) 51: 441-446, 2005.
430. Turpeinen H, Kyllonen LE, Parkkinen J, Laine J, Salmela KT, and Partanen J. Heme oxygenase 1 gene polymorphisms and outcome of renal transplantation. Int J Immunogenet 34: 253-257, 2007.
431. Udono-Fujimori R, Takahashi K, Takeda K, Furuyama K, Kaneko K, Takahashi S, Tamai M, and Shibahara S. Expression of heme oxygenase-1 is repressed by interferon-gamma and induced by hypoxia in human retinal pigment epithelial cells. Eur J Biochem 271: 3076-3084, 2004.
432. Urbich C, Dernbach E, Zeiher AM, and Dimmeler S. Double-edged role of statins in angiogenesis signaling. Circ Res 90: 737-744, 2002.
433. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, and Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89: E1-E7, 2001.
434. Vera T, Kelsen S, Yanes LL, Reckelhoff JF, and Stec DE. HO-1 induction lowers blood pressure and superoxide production in the renal medulla of angiotensin II hypertensive mice. Am J Physiol Regul Integr Comp Physiol 292: R1472-R1478, 2007.
435. Vile GF and Tyrrell RM. Oxidative stress resulting from ultraviolet A irradiation of human skin fibroblasts leads to a heme oxygenase-dependent increase in ferritin. J Biol Chem 268: 14678-14681, 1993.
436. Vile GF, Basu-Modak S, Waltner C, and Tyrrell RM. Heme oxygenase 1 mediates an adaptive response to oxidative stress in human skin fibroblasts. Proc Natl Acad Sci U S A 91: 2607-2610, 1994.
437. Visner GA, Lu F, Zhou H, Liu J, Kazemfar K, and Agarwal A. Rapamycin induces heme oxygenase-1 in human pulmonary vascular cells: implications in the antiproliferative response to rapamycin. Circulation 107: 911-916, 2003.
438. Vulapalli SR, Chen Z, Chua BH, Wang T, and Liang CS. Cardioselective overexpression of HO-1 prevents I/R-induced cardiac dysfunction and apoptosis. Am J Physiol Heart Circ Physiol 283: H688-H694, 2002.
439. Wagner KR, Hua Y, de Courten-Myers GM, Broderick JP, Nishimura RN, Lu SY, and Dwyer BE. Tin-mesoporphyrin, a potent heme oxygenase inhibitor, for treatment of intracerebral hemorrhage: in vivo and in vitro studies. Cell Mol Biol (Noisy-le-grand) 46: 597-608, 2000.
440. Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD, Kang MI, Kobayashi A, Yamamoto M, Kensler TW, and Talalay P. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci U S A 101: 2040-2045, 2004.
441. Wakabayashi N, Itoh K, Wakabayashi J, Motohashi H, Noda S, Takahashi S, Imakado S, Kotsuji T, Otsuka F, Roop DR, Harada T, Engel JD, and Yamamoto M. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat Genet 35: 238-245, 2003.
442. Wang LJ, Lee TS, Lee FY, Pai RC, and Chau LY. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 152: 711-720, 1998.
443. Wang R, Wu L, and Wang Z. The direct effect of carbon monoxide on KCa channels in vascular smooth muscle cells. Pflugers Arch 434: 285-291, 1997.
444. Wang R, Wang Z, and Wu L. Carbon monoxide-induced vasorelaxation and the underlying mechanisms. Br J Pharmacol 121: 927-934, 1997.
445. Wang R, Shamloul R, Wang X, Meng Q, and Wu L. Sustained normalization of high blood pressure in spontaneously hypertensive rats by implanted hemin pump. Hypertension 48: 685-692, 2006.
446. Wang WW, Smith DL, and Zucker SD. Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats. Hepatology 40: 424-433, 2004.
447. Wang Y, Huang S, Sah VP, Ross J Jr, Brown JH, Han J, and Chien KR. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem 273: 2161-2168, 1998.
448. Warabi E, Takabe W, Minami T, Inoue K, Itoh K, Yamamoto M, Ishii T, Kodama T, and Noguchi N. Shear stress stabilizes NF-E2-related factor 2 and induces antioxidant genes in endothelial cells: role of reactive oxygen/nitrogen species. Free Radic Biol Med 42: 260-269, 2007.
449. Was H, Cichon T, Smolarczyk R, Rudnicka D, Stopa M, Chevalier C, Leger JJ, Lackowska B, Grochot A, Bojkowska K, Ratajska A, Kieda C, Szala S, Dulak J, and Jozkowicz A. Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice. Am J Pathol 169: 2181-2198, 2006.
450. Weiss G, Werner-Felmayer G, Werner ER, Grunewald K, Wachter H, and Hentze MW. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J Exp Med 180: 969-976, 1994.
451. Wenzel P, Oelze M, Coldewey M, Hortmann M, Seeling A, Hink U, Mollnau H, Stalleicken D, Weiner H, Lehmann J, Li H, Forstermann U, Munzel T, and Daiber A. Heme oxygenase-1: a novel key player in the development of tolerance in response to organic nitrates. Arterioscler Thromb Vasc Biol 27: 1729-1735, 2007.
452. White KA and Marletta MA. Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry 31: 6627-6631, 1992.
453. Wiesel P, Patel AP, Carvajal IM, Wang ZY, Pellacani A, Maemura K, DiFonzo N, Rennke HG, Layne MD, Yet SF, Lee ME, and Perrella MA. Exacerbation of chronic renovascular hypertension and acute renal failure in heme oxygenase-1-deficient mice. Circ Res 88: 1088-1094, 2001.
454. Wilks A. Heme oxygenase: evolution, structure, and mechanism. Antioxid Redox Signal 4: 603-614, 2002.
455. Willam C, Nicholls LG, Ratcliffe PJ, Pugh CW, and Maxwell PH. The prolyl hydroxylase enzymes that act as oxygen sensors regulating destruction of hypoxia-inducible factor alpha. Adv Enzyme Regul 44: 75-92, 2004.
456. Williams KJ, Telfer BA, Airley RE, Peters HP, Sheridan MR, van der Kogel AJ, Harris AL, and Stratford IJ. A protective role for HIF-1 in response to redox manipulation and glucose deprivation: implications for tumorigenesis. Oncogene 21: 282-290, 2002.
457. Won KC, Moon JS, Eun MJ, Yoon JS, Chun KA, Cho IH, Kim YW, and Lee HW. A protective role for heme oxygenase-1 in INS-1 cells and rat islets that are exposed to high glucose conditions. J Korean Med Sci 21: 418-424, 2006.
458. Wu BJ, Kathir K, Witting PK, Beck K, Choy K, Li C, Croft KD, Mori TA, Tanous D, Adams MR, Lau AK, and Stocker R. Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J Exp Med 203: 1117-1127, 2006.
459. Wu J, Hua Y, Keep RF, Nakamura T, Hoff JT, and Xi G. Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke 34: 2964-2969, 2003.
460. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, and Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103: 129-135, 1999.
461. Yamada N, Yamaya M, Okinaga S, Nakayama K, Sekizawa K, Shibahara S, and Sasaki H. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 66: 187-195, 2000.
462. Yamashita K, McDaid J, Ollinger R, Tsui TY, Berberat PO, Usheva A, Csizmadia E, Smith RN, Soares MP, and Bach FH. Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts. FASEB J 18: 765-767, 2004.
463. Yamashita K, Ollinger R, McDaid J, Sakahama H, Wang H, Tyagi S, Csizmadia E, Smith NR, Soares MP, and Bach FH. Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs. FASEB J 20: 776-778, 2006.
464. Yang G, Nguyen X, Ou J, Rekulapelli P, Stevenson DK, and Dennery PA. Unique effects of zinc protoporphyrin on HO-1 induction and apoptosis. Blood 97: 1306-1313, 2001.
465. Yang L, Quan S, Nasjletti A, Laniado-Schwartzman M, and Abraham NG. Heme oxygenase-1 gene expression modulates angiotensin II-induced increase in blood pressure. Hypertension 43: 1221-1226, 2004.
466. Yano Y, Ozono R, Oishi Y, Kambe M, Yoshizumi M, Ishida T, Omura S, Oshima T, and Igarashi K. Genetic ablation of the transcription repressor Bach1 leads to myocardial protection against ischemia/reperfusion in mice. Genes Cells 11: 791-803, 2006.
467. Yee EL, Pitt BR, Billiar TR and Kim YM. Effect of nitric oxide on heme metabolism in pulmonary artery endothelial cells. Am J Physiol 271: L512-L518, 1996.
468. Yet SF, Layne MD, Liu X, Chen YH, Ith B, Sibinga NE, and Perrella MA. Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J 17: 1759-1761, 2003.
469. Yet SF, Perrella MA, Layne MD, Hsieh CM, Maemura K, Kobzik L, Wiesel P, Christou H, Kourembanas S, and Lee ME. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest 103: R23-R29, 1999.
470. Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, Solovyeva M, Ith B, Melo LG, Zhang L, Ingwall JS, Dzau VJ, Lee ME, and Perrella MA. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 89: 168-173, 2001.
471. Yoshida T and Kikuchi G. Sequence of the reaction of heme catabolism catalyzed by the microsomal heme oxygenase system. FEBS Lett 48: 256-261, 1974.
472. Yoshida T, Biro P, Cohen T, Muller RM, and Shibahara S. Human heme oxygenase cDNA and induction of its mRNA by hemin. Eur J Biochem 171: 457-461, 1988.
473. Yoshida T, Maulik N, Ho YS, Alam J, and Das DK. H(mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: a study with transgenic mice heterozygous for targeted disruption of the heme oxygenase-1 gene. Circulation 103: 1695-1701, 2001.
474. Zabel P, Schade FU, and Schlaak M. Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology 187: 447-463, 1993.
475. Zhang F, Kaide J, Wei Y, Jiang H, Yu C, Balazy M, Abraham NG, Wang W, and Nasjletti A. Carbon monoxide produced by isolated arterioles attenuates pressure-induced vasoconstriction. Am J Physiol Heart Circ Physiol 281: H350-H358, 2001.
476. Zhang M, Zhang BH, Chen L, and An W. Overexpression of heme oxygenase-1 protects smooth muscle cells against oxidative injury and inhibits cell proliferation. Cell Res 12: 123-132, 2002.
477. Zhang S, Lu S, Ge J, Guo J, Chen P, Li T, Zhang P, Jia Z, Ma K, Liu Y, Zhou C, and Li L. Increased heme oxygenase-1 expression in infarcted rat hearts following human bone marrow mesenchymal cell transplantation. Microvasc Res 69: 64-70, 2005.
478. Zhang X, Shan P, Alam J, Davis RJ, Flavell RA, and Lee PJ. Carbon monoxide modulates Fas/Fas ligand, caspases, and Bcl-2 family proteins via the p38alpha mitogen-activated protein kinase pathway during ischemia-reperfusion lung injury. J Biol Chem 278: 22061-22070, 2003.
479. Zhang X, Lu L, Dixon C, Wilmer W, Song H, Chen X, and Rovin BH. Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-delta12,14- prostaglandin J2 in human mesangial cells. Kidney Int 65: 798-810, 2004.
480. Zhang YC, Pileggi A, Agarwal A, Molano RD, Powers M, Brusko T, Wasserfall C, Goudy K, Zahr E, Poggioli R, Scott-Jorgensen M, Campbell-Thompson M, Crawford JM, Nick H, Flotte T, Ellis TM, Ricordi C, Inverardi L, and Atkinson MA. Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice. Diabetes 52: 708-716, 2003.
481. Zhou H, Liu H, Porvasnik SL, Terada N, Agarwal A, Cheng Y, and Visner GA. Heme oxygenase-1 mediates the protective effects of rapamycin in monocrotaline-induced pulmonary hypertension. Lab Invest 86: 62-71, 2006.
482. Zou AP, Billington H, Su N, and Cowley AW Jr. Expression and actions of heme oxygenase in the renal medulla of rats. Hypertension 35: 342-347, 2000.